syndrome	score	normalized_score
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIa; GP3A;;GP IIIa;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	2.0	100.0
MYOCLONIC EPILEPSY OF LAFORA	1.5181307999999998	75.90653999999999
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	1.5	75.0
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	1.4937724720000003	74.68862360000001
#604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1;;VACUOLATING MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS;;LVM;;VL;;LEUKOENCEPHALOPATHY WITH SWELLING AND CYSTS;;VAN DER KNAAP DISEASE	1.334248751	66.71243755
D-2-HYDROXYGLUTARIC ACIDURIA 1	1.312397223	65.61986115
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.3055556	65.27777999999999
3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY	1.1011135900000002	55.05567950000001
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	1.0844468900000002	54.222344500000005
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	1.0833333	54.166665
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	1.0819398	54.09699
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	1.0688699600000002	53.44349800000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	1.0611207230000002	53.05603615000001
ABLEPHARON-MACROSTOMIA SYNDROME	1.0434783	52.173915
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	1.0431579720000002	52.15789860000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	1.0333754030000002	51.66877015000001
MOWAT-WILSON SYNDROME; MOWS	1.025307491	51.26537455
TRANSSEXUALITY	1.0188679	50.943395
MEVALONIC ACIDURIA; MEVA	1.0148856720000001	50.7442836
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	1.014727931	50.736396549999995
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	1.0133333	50.666665
ARTHROGRYPOSIS, DISTAL, TYPE 2A	1.0115199209999999	50.57599604999999
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	1.008145872	50.4072936
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	1.00724638	50.362319
FRONTONASAL DYSPLASIA 1; FND1	1.00704225	50.352112500000004
SPLENOPORTAL VASCULAR ANOMALIES	1.00440529	50.2202645
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	1.00440529	50.2202645
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	1.0028732230000001	50.14366115000001
HAMAMY SYNDROME; HMMS	1.00260417	50.130208499999995
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.001759633	50.08798165
HYDROXYKYNURENINURIA	1.000843882	50.0421941
HEPATOCELLULAR CARCINOMA	1.0	50.0
PORTAL VEIN, CAVERNOUS TRANSFORMATION OF	1.0	50.0
PHEOCHROMOCYTOMA	1.0	50.0
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	1.0	50.0
AGENESIS OF CEREBRAL WHITE MATTER	1.0	50.0
WILSON DISEASE	1.0	50.0
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	1.0	50.0
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	1.0	50.0
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	1.0	50.0
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	1.0	50.0
#615207 IL21R IMMUNODEFICIENCY	1.0	50.0
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.9484126	47.42063
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.883141443	44.15707215
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.8600871099999999	43.004355499999996
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.765549782	38.277489100000004
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.6388886	31.94443
HALOTHANE HEPATITIS	0.6147059	30.735295
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.6065887999999999	30.329439999999998
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.604323733	30.216186649999997
THROMBOCYTOPENIA 1	0.6005744	30.028719999999996
BARE LYMPHOCYTE SYNDROME, TYPE II	0.6	30.0
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.6	30.0
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.6	30.0
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.587576971	29.378848549999997
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.58444659	29.2223295
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.5842487510000001	29.212437550000004
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.583333	29.16665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.57566402	28.783201000000002
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.5555556	27.777780000000003
COMBINED SAPOSIN DEFICIENCY	0.54756461	27.3782305
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.5436715900000001	27.183579500000004
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.543402351	27.17011755
AICARDI SYNDROME; AIC	0.5405988100000001	27.029940500000006
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.537771982	26.8885991
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.5357143	26.785715
TRICHOHEPATOENTERIC SYNDROME 1	0.5333333	26.666665000000002
Congenital disorder of glycosylation, type IIh	0.532532282	26.6266141
AICARDI-GOUTIERES SYNDROME 5	0.529781502	26.489075099999997
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.528071752	26.4035876
EPILEPSY, BENIGN NEONATAL, 2	0.5147059	25.735295
IMMUNODEFICIENCY 36; IMD36	0.51240529	25.6202645
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 1	0.51008711	25.5043555
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.5094068900000001	25.470344500000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.508620353	25.431017649999998
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.508090262	25.4045131
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.5028732229999999	25.143661149999996
BRANCHIOOTORENAL SYNDROME 1	0.50280112	25.140056
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.502029341	25.101467049999997
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.501957472	25.0978736
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.5017596329999999	25.087981649999996
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.50111359	25.0556795
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.5010341229999999	25.051706149999998
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.500915751	25.04578755
#603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3	0.500915751	25.04578755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.500674272	25.033713600000002
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.5	25.0
PHLEBECTASIA OF LIPS	0.5	25.0
IMMUNE DEFICIENCY DISEASE	0.5	25.0
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	25.0
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.5	25.0
247150 LIP PRINTS	0.5	25.0
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	25.0
#604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2;;GEFS+, TYPE 2; GEFS+2FEBRILE SEIZURES, FAMILIAL, 3A, INCLUDED; FEB3A, INCLUDED	0.46636890000000003	23.318445
CENTRALOPATHIC EPILEPSY	0.4484126	22.42063
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.4484126	22.42063
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.4484126	22.42063
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.416667	20.83335
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.411674611	20.583730550000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.396277972	19.813898599999998
#230600 GM1-GANGLIOSIDOSIS, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, JUVENILE TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE II;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 2GANGLIOSIDOSIS, GENERALIZED GM1, LATE-INFANTILE TYPE, INCLUDED	0.3868371	19.341855
PSEUDOXANTHOMA ELASTICUM; PXE	0.38361402	19.180701
#605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2;;CONVULSIONS, BENIGN FAMILIAL INFANTILE, 2; BFIC2	0.3824787	19.123935
#602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;ICCA;;INFANTILE CONVULSIONS AND PAROXYSMAL CHOREOATHETOSIS, FAMILIAL;;ICCA SYNDROME;;PAROXYSMAL KINESIGENIC DYSKINESIA WITH INFANTILE CONVULSIONS; PKD/IC	0.3824787	19.123935
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.38228480200000003	19.114240100000004
EPILEPSY, JUVENILE ABSENCE	0.3752738	18.76369
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.3752738	18.76369
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.373138043	18.65690215
PROPIONIC ACIDEMIA	0.365262233	18.26311165
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.36383518	18.191758999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.362568782	18.128439099999998
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.3613516	18.06758
#607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 6, INCLUDED; EJM6,INCLUDED	0.3596488	17.98244
AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL	0.35824562	17.912281
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.35622986300000004	17.81149315
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.349801882	17.4900941
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.3480389	17.401944999999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.341619382	17.0809691
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.341495131	17.07475655
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.341495131	17.07475655
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.336781052	16.839052600000002
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.336206223	16.81031115
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.33620622299999997	16.810311149999997
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.33593717	16.7968585
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.335362341	16.76811705
ALSTROM SYNDROME; ALMS	0.334569702	16.7284851
#300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 30; MRXS30	0.334248751	16.71243755
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.334248751	16.71243755
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.334248751	16.71243755
GRANGE SYNDROME; GRNG	0.333333	16.66665
#608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD;;APLD, SUSCEPTIBILITY TO;;BARRAQUER-SIMONS SYNDROME;;LIPODYSTROPHY, CEPHALOTHORACIC TYPE;;LIPODYSTROPHY, PARTIAL, PROGRESSIVE	0.333333	16.66665
PARAGANGLIOMAS 1	0.333333	16.66665
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.333333	16.66665
DANDY-WALKER SYNDROME	0.333333	16.66665
IMMUNODEFICIENCY 46; IMD46	0.333333	16.66665
PSEUDO-VON WILLEBRAND DISEASE	0.333333	16.66665
PARAGANGLIOMAS 4	0.333333	16.66665
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.333333	16.66665
Microangiopathy and leukoencephalopathy, pontine, autosomal dominant	0.333333	16.66665
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.333333	16.66665
PARAGANGLIOMAS 3	0.333333	16.66665
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.333333	16.66665
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.333333	16.66665
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.333333	16.66665
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.331351212	16.5675606
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.328077782	16.4038891
TUBEROUS SCLEROSIS	0.32591575100000003	16.29578755
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.31636785100000003	15.818392550000002
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.30550482300000004	15.275241150000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.294698472	14.7349236
#602398 DESMOSTEROLOSIS	0.288110853	14.40554265
GLUTAMINE DEFICIENCY, CONGENITAL	0.28766487100000004	14.383243550000003
MYASTHENIA GRAVIS; MG	0.2833333	14.166665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.282036302	14.101815100000001
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.27898025000000004	13.949012500000002
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.2775264	13.87632
CHROMOSOME 1P36 DELETION SYNDROME	0.26240747300000006	13.120373650000003
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.262044582	13.1022291
INFANTILE LIVER FAILURE SYNDROME 2	0.258162131	12.908106550000001
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.25710415100000006	12.855207550000003
Pontine tegmental cap dysplasia	0.256457453	12.82287265
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.25568182	12.784091
CEPHALIN LIPIDOSIS	0.25408163	12.704081500000001
LOWE OCULOCEREBRORENAL SYNDROME	0.25351992100000004	12.675996050000002
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.25280112	12.640056
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.252029341	12.60146705
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.25175963300000004	12.587981650000001
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.25111359	12.5556795
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.25111359	12.5556795
#252011 MITOCHONDRIAL COMPLEX II DEFICIENCY;;SUCCINATE CoQ REDUCTASE DEFICIENCY	0.250915751	12.545787550000002
#604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF;;EPILEPSY, PARTIAL, WITH VARIABLE FOCI; FPEVF	0.25	12.5
HYPERPARATHYROIDISM 2	0.25	12.5
PATENT DUCTUS VENOSUS	0.25	12.5
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.25	12.5
#300367 THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA;XLTDA	0.25	12.5
#614379 COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD ;;C4B DEFICIENCY	0.25	12.5
DYSTONIA 6, TORSION	0.25	12.5
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.25	12.5
TUFTSIN DEFICIENCY	0.25	12.5
CEROID STORAGE DISEASE	0.25	12.5
HYPEREKPLEXIA 1; HKPX1	0.25	12.5
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	12.5
118900 CIRRHOSIS, FAMILIAL	0.25	12.5
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.25	12.5
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	12.5
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.2244281	11.221404999999999
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.2244281	11.221404999999999
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.2244281	11.221404999999999
LATHOSTEROLOSIS	0.218696341	10.93481705
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.218164363	10.90821815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.212827072	10.6413536
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.212827072	10.6413536
COHEN SYNDROME	0.207776471	10.38882355
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.206044251	10.30221255
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1	0.20440529000000002	10.2202645
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.20287322300000002	10.143661150000002
PEHO-LIKE SYNDROME; PEHOL	0.202783512	10.1391756
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.202029341	10.10146705
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.201957472	10.0978736
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.201957472	10.0978736
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.20044194099999998	10.02209705
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.2	10.0
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4	0.2	10.0
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.196642311	9.83211555
ADAMS-OLIVER SYNDROME 1; AOS1	0.195548793	9.77743965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.19441408200000002	9.7207041
PHELAN-MCDERMID SYNDROME; PHMDS	0.19429272299999997	9.714636149999999
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.18988343300000005	9.494171650000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.188042543	9.40212715
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.18677257199999997	9.338628599999998
PEHO SYNDROME; PEHO	0.18594495300000002	9.297247650000001
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.182143382	9.1071691
#613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7;;GEFS+, TYPE 7; GEFS+7FEBRILE SEIZURES, FAMILIAL, 3B, INCLUDED; FEB3B, INCLUDED	0.1812995	9.064975
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.17718611999999997	8.859305999999998
NIEMANN-PICK DISEASE, TYPE C2	0.173945513	8.69727565
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.173945513	8.69727565
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.17347043199999998	8.673521599999999
COFFIN-SIRIS SYNDROME 6; CSS6	0.17142559200000002	8.5712796
PYRUVATE CARBOXYLASE DEFICIENCY	0.16954022300000002	8.477011150000001
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.16954022300000002	8.477011150000001
GLUTARIC ACIDEMIA I; GA1	0.168696341	8.43481705
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.166667	8.333350000000001
BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16	0.166667	8.333350000000001
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.166667	8.333350000000001
#613112 MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED	0.166667	8.333350000000001
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.166667	8.333350000000001
JOUBERT SYNDROME 2	0.164457472	8.2228736
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.164117141	8.20585705
DUBOWITZ SYNDROME	0.16381615999999996	8.190807999999999
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.15888079	7.9440395
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.15743713299999998	7.871856649999999
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.157244382	7.862219099999999
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.15652299	7.8261495
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.15489663099999998	7.744831549999999
GENITOPATELLAR SYNDROME; GTPTS	0.15446089199999996	7.723044599999998
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.15387375099999998	7.693687549999999
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.152868172	7.6434086
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.15185541100000002	7.592770550000001
GLYCEROL KINASE DEFICIENCY; GKD	0.14722080299999998	7.361040149999999
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.14481447199999997	7.240723599999999
#613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12	0.1433483	7.167415000000001
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.14270491200000002	7.135245600000001
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.14175584100000002	7.087792050000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.140642702	7.0321351000000005
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.140297712	7.0148855999999995
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.14006922000000002	7.0034610000000015
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.138123233	6.9061616500000005
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.13777582000000002	6.888791000000001
219400 CYANOSIS AND HEPATIC DISEASE	0.1357143	6.785715000000001
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.135351923	6.767596150000001
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.134961923	6.74809615
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.13485068000000003	6.742534000000002
#613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 5, SUSCEPTIBILITYTO, INCLUDED; GEFS5, INCLUDED;;GEFS+, TYPE 5, SUSCEPTIBILITY TO, INCLUDED;;GEFS+5, SUSCEPTIBILITY TO, INCLUDED;;GEFSP5, SUSCEPTIBILITY TO, INCLUDED;;EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 7, INCLUDED; EJM7,INCLUDED	0.1344245	6.7212250000000004
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.13310794099999998	6.655397049999999
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx;;CDG-x	0.129997381	6.49986905
TARP SYNDROME; TARPS	0.12973652200000002	6.486826100000001
TUBEROUS SCLEROSIS 2; TSC2	0.125915751	6.29578755
#604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1;;GEFS+, TYPE 1; GEFS+1	0.1257439	6.287195
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.12454491200000002	6.227245600000001
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.123593373	6.17966865
TURNPENNY-FRY SYNDROME; TPFS	0.122568012	6.1284006
MUCOLIPIDOSIS IV; ML4	0.12100507200000002	6.050253600000001
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.119483381	5.97416905
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.11864273300000003	5.932136650000001
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.11724140000000001	5.86207
COACH SYNDROME	0.116645333	5.83226665
COFFIN-SIRIS SYNDROME 2; CSS2	0.116206523	5.81032615
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.11473408300000001	5.7367041500000004
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.114416951	5.72084755
#604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PPARG MUTATIONS	0.11402882	5.701441
EVEN-PLUS SYNDROME	0.11394673200000001	5.697336600000001
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.11366438200000001	5.6832191000000005
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.1130708	5.65354
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.11296033300000002	5.6480166500000015
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.11193099200000002	5.596549600000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.111256371	5.56281855
COFFIN-SIRIS SYNDROME 3; CSS3	0.108620353	5.43101765
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.10818720000000001	5.40936
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.10818077200000001	5.409038600000001
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.1081087	5.405435
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.10750485100000001	5.37524255
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.106904482	5.345224099999999
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.10660282300000001	5.330141150000001
SECKEL SYNDROME 2; SCKL2	0.10574713000000001	5.2873565000000005
WITTEVEEN-KOLK SYNDROME	0.10572822300000002	5.286411150000001
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.10568182000000001	5.284091
WHITE-SUTTON SYNDROME; WHSUS	0.105541702	5.2770851
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.10475859200000001	5.2379296
DEHYDRATED HEREDITARY STOMATOCYTOSIS 1 WITH OR WITHOUT PSEUDOHYPERKALEMIA AND/OR PERINATAL EDEMA; DHS1	0.10440529000000001	5.220264500000001
#613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3	0.10440529000000001	5.220264500000001
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.10411180100000002	5.2055900500000005
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.10409768300000002	5.204884150000002
COFFIN-SIRIS SYNDROME 4; CSS4	0.102873223	5.14366115
DYSTONIA, JUVENILE-ONSET	0.10280112000000001	5.140056
#614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T;;CDG It; CDGIt;;PHOSPHOGLUCOMUTASE 1 DEFICIENCY;;PGM1 DEFICIENCY;;GLYCOGEN STORAGE DISEASE XIV; GSD14;;GSD XIV	0.10280112000000001	5.140056
MEIER-GORLIN SYNDROME 5; MGORS5	0.10260417000000001	5.1302085
JOUBERT SYNDROME 7	0.10195747200000001	5.097873600000001
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.10149766300000002	5.074883150000001
IMMUNODEFICIENCY 37; IMD37	0.10091575100000001	5.045787550000001
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.10091575100000001	5.045787550000001
#262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2;;PANHYPOPITUITARISM;;ATELIOTIC DWARFISM WITH HYPOGONADISM;;PITUITARY DWARFISM III;;HANHART DWARFISM	0.10091575100000001	5.045787550000001
KRABBE DISEASE	0.10007393099999999	5.00369655
TRICHOHEPATOENTERIC SYNDROME 2	0.1	5.0
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.1	5.0
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.1	5.0
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.1	5.0
#613783 COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD;;C1s DEFICIENCY	0.1	5.0
#256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1;;PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PHHI;;HYPOGLYCEMIA, HYPERINSULINEMIC, OF INFANCY;;HYPERINSULINEMIC HYPOGLYCEMIA DUE TO FOCAL ADENOMATOUS HYPERPLASIA;;NESIDIOBLASTOSIS OF PANCREAS;;HYPERINSULINISM, FAMILIAL, WITH PANCREATIC NESIDIOBLASTOSIS;;HYPERINSULINISM, CONGENITAL	0.1	5.0
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.1	5.0
HEPATITIS B VACCINE, RESPONSE TO	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.1	5.0
PANENCEPHALITIS, SUBACUTE SCLEROSING	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.1	5.0
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.1	5.0
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.099001851	4.95009255
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.09771182	4.885591
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.096634882	4.8317441
SITOSTEROLEMIA	0.09531439000000001	4.7657195
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.09521061100000001	4.76053055
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.09499073000000001	4.7495365000000005
HALLERMANN-STREIFF SYNDROME; HSS	0.09461279	4.7306395000000006
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.09371310100000001	4.68565505
TENORIO SYNDROME; TNORS	0.09293844100000001	4.646922050000001
OROFACIODIGITAL SYNDROME XIV; OFD14	0.092014622	4.6007311
#276710 TYROSINEMIA, TYPE III; TYRSN3;;4-@HYDROXYPHENYLPYRUVIC ACID OXIDASE DEFICIENCY;;4-@HYDROXYPHENYLPYRUVATE DIOXYGENASE DEFICIENCY	0.09182485100000001	4.5912425500000005
HEART AND BRAIN MALFORMATION SYNDROME	0.091219353	4.56096765
ATRANSFERRINEMIA	0.0909091	4.5454550000000005
HYPERVITAMINOSIS A, SUSCEPTIBILITY TO	0.0909091	4.5454550000000005
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.0909091	4.5454550000000005
RCAD (renal cysts and diabetes)	0.0909091	4.5454550000000005
FIBROSCLEROSIS, MULTIFOCAL	0.0909091	4.5454550000000005
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.08979075300000001	4.489537650000001
NIEMANN-PICK DISEASE, TYPE B	0.08932839000000001	4.466419500000001
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.08888261100000001	4.444130550000001
#614018 EPILEPSY, PROGRESSIVE MYOCLONIC, 6; EPM6	0.0888158	4.44079
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.08812380000000002	4.4061900000000005
RHEUMATOID ARTHRITIS	0.08791550000000001	4.395775
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.08724400000000002	4.3622000000000005
#613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45	0.08691753	4.3458765
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.086712241	4.33561205
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.08620652300000002	4.310326150000001
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.08620652300000001	4.310326150000001
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.08613442000000002	4.3067210000000005
ACROCALLOSAL SYNDROME; ACLS	0.085905481	4.295274050000001
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.08529077200000001	4.264538600000001
CAROLI DISEASE, ISOLATED	0.08427718000000001	4.213859
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.08417718200000002	4.208859100000001
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.08417718200000002	4.208859100000001
JOUBERT SYNDROME 23; JBTS23	0.08417718200000002	4.208859100000001
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE V; ALPS5	0.08414669000000001	4.207334500000001
#615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF	0.08372582	4.186291000000001
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.08372582	4.186291000000001
JOUBERT SYNDROME 1	0.08368827200000001	4.1844136
LISSENCEPHALY 2; LIS2	0.083514112	4.1757056
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.08342490200000002	4.171245100000001
#615268 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME4; CAMRQ4;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 4	0.08333330000000001	4.166665000000001
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.08260492000000001	4.1302460000000005
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.081553702	4.0776851
LISSENCEPHALY 5; LIS5	0.081513071	4.07565355
TANGIER DISEASE; TGD	0.08132839000000001	4.0664195
MICROHYDRANENCEPHALY; MHAC	0.08104598	4.0522990000000005
LISSENCEPHALY, X-LINKED, 2	0.080933991	4.04669955
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.080832261	4.0416130500000005
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.08004895300000002	4.002447650000001
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN	0.079832	3.9916
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.079802331	3.99011655
AUTOIMMUNE DISEASE, MULTISYSTEM, INFANTILE-ONSET, 1; ADMIO1	0.0797414	3.98707
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.07886889999999999	3.9434449999999996
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.07837063	3.9185315
#612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B	0.078125	3.90625
HARDIKAR SYNDROME	0.07755271000000001	3.8776355000000007
COFFIN-SIRIS SYNDROME 1; CSS1	0.077536953	3.87684765
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.077384212	3.8692105999999997
CANAVAN DISEASE	0.07692310000000001	3.8461550000000004
MCLEOD SYNDROME; MCLDS	0.07692310000000001	3.8461550000000004
HYPERLIPOPROTEINEMIA, TYPE V	0.07692310000000001	3.8461550000000004
#605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET;;CHOLESTASIS, NEONATAL INTRAHEPATIC, CAUSED BY CITRIN DEFICIENCY; NICCD	0.07692310000000001	3.8461550000000004
HYPOALPHALIPOPROTEINEMIA, PRIMARY	0.07692310000000001	3.8461550000000004
MYOCLONUS AND ATAXIA	0.07692310000000001	3.8461550000000004
FISH-EYE DISEASE	0.07692310000000001	3.8461550000000004
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.07692310000000001	3.8461550000000004
ATHEROSCLEROSIS SUSCEPTIBILITY	0.07692310000000001	3.8461550000000004
#615604 L-FERRITIN DEFICIENCY; LFTD	0.07692310000000001	3.8461550000000004
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.07683389000000002	3.841694500000001
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.07674234299999999	3.8371171499999996
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.075699211	3.78496055
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.07490529000000001	3.7452645000000007
WILLIAMS-BEUREN SYNDROME; WBS	0.07461574	3.730787
CORNELIA DE LANGE SYNDROME 1	0.074502861	3.7251430500000002
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.0744235	3.721175
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.07422972000000001	3.7114860000000007
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.07403277000000001	3.7016385000000005
Polyarteritis nodosa, childhood-onset	0.07353291	3.6766455000000002
MYELOPEROXIDASE DEFICIENCY	0.07312923000000002	3.6564615000000007
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0728901	3.644505
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.07186239999999999	3.59312
YUNIS-VARON SYNDROME	0.07145224	3.572612
KABUKI SYNDROME 1	0.070778513	3.53892565
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.07050000000000001	3.5250000000000004
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.0702615	3.513075
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.0702615	3.513075
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.06954225	3.4771125
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.069053073	3.4526536500000002
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.06900103300000002	3.4500516500000007
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.068845063	3.44225315
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.06871995	3.4359975
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.06801888	3.400944
POTOCKI-LUPSKI SYNDROME	0.06764625299999999	3.3823126499999994
MICROPHTHALMIA, SYNDROMIC 1	0.067133511	3.3566755500000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.066916641	3.34583205
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA	0.06690529	3.3452645000000003
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.06690529	3.3452645000000003
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE III; ALPS3	0.06690529	3.3452645000000003
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.06658163	3.3290815
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.06620652299999999	3.3103261499999994
#154780 MARSHALL SYNDROME; MRSHS	0.06613442	3.306721
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.0660173	3.300865
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.065952723	3.29763615
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.06488696000000001	3.2443480000000005
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.064653372	3.2326686000000002
WARSAW BREAKAGE SYNDROME; WABS	0.064457472	3.2228736000000002
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.064457472	3.2228736000000002
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.06435518100000001	3.2177590500000006
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.06424905100000002	3.212452550000001
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.064177182	3.2088590999999997
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.064163	3.20815
Growth hormone deficiency, isolated, type IA	0.0636363	3.1818150000000003
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.06361886300000001	3.1809431500000005
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.06361826100000001	3.1809130500000005
PAPILLORENAL SYNDROME	0.063415751	3.1707875500000005
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.06333330000000001	3.1666650000000005
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.06333330000000001	3.1666650000000005
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.06324389999999999	3.1621949999999996
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.06324389999999999	3.1621949999999996
MENTAL RETARDATION, X-LINKED 98; MRX98	0.062568333	3.12841665
ANTIPHOSPHOLIPID SYNDROME, FAMILIAL	0.0625	3.125
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.0625	3.125
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0625	3.125
IMMUNODEFICIENCY 62; IMD62	0.0625	3.125
COLOBOMA, OCULAR	0.0625	3.125
COLOBOMA OF OPTIC NERVEOPTIC NERVE HEAD PITS, BILATERAL CONGENITAL, INCLUDED	0.0625	3.125
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.0625	3.125
SPASTIC PARAPLEGIA AND EVANS SYNDROME	0.0625	3.125
PELVIS-SHOULDER DYSPLASIA	0.0625	3.125
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.062204583	3.11022915
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.06118664299999999	3.0593321499999995
BAZEX SYNDROME; BZX	0.0607197	3.035985
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.060653401	3.03267005
#254770 EPILEPSY, MYOCLONIC JUVENILE; EJM;;MYOCLONIC EPILEPSY, JUVENILE; JME;;PETIT MAL, IMPULSIVE;;JANZ SYNDROMEMYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1, INCLUDED; EJM1,INCLUDED	0.0598896	2.9944800000000003
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.059813901	2.9906950500000002
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.059552781000000006	2.9776390500000005
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.059451933	2.97259665
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.05882701	2.9413505
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.05880589	2.9402945
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.05877778299999999	2.9388891499999996
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.058245171	2.91225855
CYCLIC NEUTROPENIA	0.058184200000000005	2.9092100000000003
CHROMOSOME 17q12 DELETION SYNDROME	0.058159770000000006	2.9079885000000005
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.058108993	2.90544965
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.057513072	2.8756535999999997
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0573294	2.86647
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.056894720999999995	2.84473605
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.056823702000000004	2.8411851
EPILEPSY, IDIOPATHIC GENERALIZED	0.0566467	2.832335
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.056457453	2.82287265
#300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;RESDX	0.055555600000000004	2.7777800000000004
APNEA, OBSTRUCTIVE SLEEP	0.055555600000000004	2.7777800000000004
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.055555600000000004	2.7777800000000004
#300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIORDISORDERS	0.055555600000000004	2.7777800000000004
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.055555600000000004	2.7777800000000004
EPILEPSY, PYRIDOXINE-DEPENDENT	0.055237902	2.7618951
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.054961913	2.7480956500000002
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.054864882000000004	2.7432441
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.054825490000000004	2.7412745000000003
YOU-HOOVER-FONG SYNDROME; YHFS	0.054589072	2.7294536000000003
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.054582200000000004	2.7291100000000004
#221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS;;LEUKOENCEPHALOPATHY WITH NEUROAXONAL SPHEROIDS, AUTOSOMAL DOMINANT;;GLIOSIS, FAMILIAL PROGRESSIVE SUBCORTICAL; GPSC;;DEMENTIA, FAMILIAL, NEUMANN TYPE;;SUBCORTICAL GLIOSIS OF NEUMANN	0.0545058	2.72529
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0545058	2.72529
#256520 NEU-LAXOVA SYNDROME; NLS	0.054255269999999994	2.7127635
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.05412410299999999	2.7062051499999997
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.053906363	2.69531815
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.053654282	2.6827141
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0535793	2.6789650000000003
OGDEN SYNDROME; OGDNS	0.053448052	2.6724026000000003
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.05290145300000001	2.6450726500000004
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.05280112	2.640056
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.0526316	2.63158
CHROMOSOME 18Q DELETION SYNDROME	0.052431761	2.62158805
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.052232631	2.6116315500000002
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.052117381	2.60586905
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.052117381	2.60586905
PORTAL HYPERTENSION, NONCIRRHOTIC	0.05202429	2.6012145
SCLEROSING CHOLANGITIS, NEONATAL	0.05202429	2.6012145
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.05177510199999999	2.5887550999999993
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.051360441	2.56802205
#607196 MICROCEPHALY, AMISH TYPE; MCPHA;;AMISH LETHAL MICROCEPHALY;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 3 (MICROCEPHALY TYPE); THMD3	0.05120163	2.5600815
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.05111359	2.5556795
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.050843882	2.5421941
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.050841062	2.5420531
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.05072468000000001	2.5362340000000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.050415482	2.5207740999999997
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.05040629	2.5203145
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.05037279099999999	2.5186395499999996
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.050297633	2.51488165
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.050129099999999996	2.506455
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	0.05	2.5
NASODIGITOACOUSTIC SYNDROME	0.05	2.5
DIAMOND-BLACKFAN ANEMIA 8	0.05	2.5
KEIPERT SYNDROME; KPTS	0.05	2.5
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.04981830300000001	2.49091515
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.049378633000000005	2.46893165
#604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, WITH MENTAL IMPAIRMENT ANDTHIN CORPUS CALLOSUM;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, COMPLICATED, WITH THIN CORPUSCALLOSUM;;HSP-TCC	0.04908798	2.454399
GLYCOGEN STORAGE DISEASE IV	0.04873259	2.4366295
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.048538	2.4269
FEBRILE CONVULSIONS, FAMILIAL, 9	0.048538	2.4269
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.048356413	2.41782065
RHEUMATIC FEVER-RELATED ANTIGENRHEUMATIC FEVER, ACUTE, SUSCEPTIBILITY TO, INCLUDED	0.048039200000000004	2.4019600000000003
RAGWEED SENSITIVITY	0.048039200000000004	2.4019600000000003
GABRIELE-DE VRIES SYNDROME; GADEVS	0.048031352	2.4015676
#604901 NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC	0.047619	2.38095
#267010 MECKEL SYNDROME, TYPE 7; MKS7;;RENAL-HEPATIC-PANCREATIC DYSPLASIA WITH DANDY-WALKER CYST;;GOLDSTON SYNDROME	0.047619	2.38095
#615506 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5	0.047619	2.38095
ADAMS-OLIVER SYNDROME 6; AOS6	0.047619	2.38095
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.047619	2.38095
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.047619	2.38095
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.047214133000000005	2.3607066500000005
GOLDBERG-SHPRINTZEN SYNDROME	0.046645002	2.3322501
HYPOADRENOCORTICISM, FAMILIAL	0.046623631	2.33118155
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.046321882	2.3160941
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.046298382	2.3149191
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.046298382	2.3149191
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.046166102	2.3083051
MENTAL RETARDATION, BUENOS AIRES TYPE	0.0454545	2.272725
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.0454545	2.272725
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.045287282	2.2643641
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.045079801999999995	2.2539900999999998
LISSENCEPHALY 3; LIS3	0.044707120999999996	2.2353560499999996
SHPRINTZEN OMPHALOCELE SYNDROME	0.04459189	2.2295945
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.044574489999999994	2.2287244999999998
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.04451547199999999	2.2257735999999997
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.044472541	2.2236270499999997
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.04384978	2.1924889999999997
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.043805363	2.19026815
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.043710672	2.1855336
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	0.043478300000000004	2.173915
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.043478300000000004	2.173915
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.043478300000000004	2.173915
BLEPHAROCHALASIS AND DOUBLE LIP	0.043478300000000004	2.173915
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.043478300000000004	2.173915
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.043478300000000004	2.173915
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.043478300000000004	2.173915
MAL DE MELEDA	0.043478300000000004	2.173915
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.043478300000000004	2.173915
LIP, MEDIAN NODULE OF UPPER	0.043478300000000004	2.173915
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.043478300000000004	2.173915
LIP, HAMARTOMATOUS	0.043478300000000004	2.173915
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.042979171999999996	2.1489586
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.042961481	2.14807405
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.042889612	2.1444806
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.042889612	2.1444806
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.042831812999999996	2.14159065
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.042831503	2.14157515
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.042777652	2.1388826
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.042756550000000004	2.1378275
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.042667312	2.1333656
NAVAJO NEUROHEPATOPATHY	0.042537152	2.1268576
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.04251702	2.125851
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.04243093999999999	2.1215469999999996
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.04240010000000001	2.1200050000000004
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.042194881999999996	2.1097441
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.04204573	2.1022865
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.041865582	2.0932790999999997
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.041334723	2.0667361499999997
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.04126262	2.063131
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.041255982999999996	2.06279915
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.0410217	2.051085
FUMARASE DEFICIENCY; FMRD	0.040688122	2.0344061
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.040418972000000004	2.0209486
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.040009301	2.00046505
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.039991041	1.99955205
VICI SYNDROME; VICIS	0.039947393	1.99736965
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.039912742	1.9956371000000002
MACROCYTOSIS, FAMILIAL	0.03979593000000001	1.9897965000000004
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.03979593000000001	1.9897965000000004
FLOOD FACTOR DEFICIENCY	0.03979593000000001	1.9897965000000004
COUMARIN RESISTANCE	0.03979593000000001	1.9897965000000004
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.03979593000000001	1.9897965000000004
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.03979593000000001	1.9897965000000004
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.03979593000000001	1.9897965000000004
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.03979593000000001	1.9897965000000004
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.039702221999999995	1.9851110999999997
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.03957509	1.9787545
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.03949891	1.9749455
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.039377251	1.96886255
COWDEN SYNDROME 6; CWS6	0.039377251	1.96886255
COWDEN SYNDROME 5; CWS5	0.039377251	1.96886255
SILVER-RUSSELL SYNDROME; SRS	0.039305382	1.9652691
KOOLEN-DE VRIES SYNDROME; KDVS	0.039205143000000005	1.9602571500000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.038949523	1.94747615
LISSENCEPHALY 1; LIS1	0.03875676299999999	1.9378381499999997
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.038508753	1.92543765
PELGER-HUET ANOMALY; PHA	0.038473002	1.9236501
PREPAPILLARY VASCULAR LOOPS	0.0384615	1.923075
WATSON SYNDROME	0.0384615	1.923075
MUSCULAR HYPERTONIA, LETHAL	0.0384615	1.923075
ATROPHODERMA VERMICULATA; AVA	0.0384615	1.923075
THUMB DEFORMITY	0.0384615	1.923075
VENULAR INSUFFICIENCY, SYSTEMIC	0.0384615	1.923075
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0384615	1.923075
BETHLEM MYOPATHY 1	0.0384615	1.923075
#608358 MYOPATHY, MYOSIN STORAGE;;MYOPATHY, HYALINE BODY, AUTOSOMAL DOMINANT	0.0384615	1.923075
ACRORENAL-MANDIBULAR SYNDROME	0.0384615	1.923075
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.0384615	1.923075
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0384615	1.923075
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.0384615	1.923075
HEMANGIOPERICYTOMA, MALIGNANT	0.0384615	1.923075
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0384615	1.923075
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0384615	1.923075
ARTERIES, ANOMALIES OF	0.0384615	1.923075
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0384615	1.923075
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.038421023	1.9210511499999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.038362302	1.9181151
#219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A;;ARCL1;;CUTIS LAXA, AUTOSOMAL RECESSIVE	0.038303	1.91515
JOUBERT SYNDROME 10	0.038256481999999994	1.9128240999999997
WARBURG MICRO SYNDROME 2; WARBM2	0.03823970000000001	1.9119850000000005
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.038105640999999996	1.9052820499999998
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.037593002	1.8796501
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.03758031199999999	1.8790155999999996
GITELMAN SYNDROME	0.037573931	1.87869655
#261000 INTRINSIC FACTOR DEFICIENCY; IFD;;PERNICIOUS ANEMIA, CONGENITAL, DUE TO DEFECT OF INTRINSIC FACTOR	0.037414930000000006	1.8707465000000003
BLOOD GROUP, DUFFY SYSTEM; FY	0.037414930000000006	1.8707465000000003
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.037414930000000006	1.8707465000000003
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.037389942	1.8694971
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.03719722	1.8598610000000002
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.037112792	1.8556396
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.036998622999999994	1.8499311499999997
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.03699713	1.8498565000000002
MYELOCEREBELLAR DISORDER	0.03693182	1.8465909999999999
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.0369281	1.8464049999999999
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.0369281	1.8464049999999999
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.03682789	1.8413945
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.036669842	1.8334921
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.03665818	1.832909
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.036630051000000004	1.8315025500000002
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.036404412000000004	1.8202206000000003
ZUNICH NEUROECTODERMAL SYNDROME	0.036345561	1.8172780499999999
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.03621452	1.810726
SMITH-MAGENIS SYNDROME; SMS	0.036206523000000004	1.8103261500000003
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.03596601	1.7983005
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.03577162	1.7885809999999998
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.035760923	1.78804615
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.035714300000000004	1.7857150000000002
ACETOPHENETIDIN SENSITIVITY	0.035714300000000004	1.7857150000000002
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY; BCD	0.035714300000000004	1.7857150000000002
CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.035714300000000004	1.7857150000000002
GALLBLADDER, AGENESIS OF	0.035714300000000004	1.7857150000000002
LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF	0.035714300000000004	1.7857150000000002
SULFHEMOGLOBINEMIA, CONGENITAL	0.035714300000000004	1.7857150000000002
CHANARIN-DORFMAN SYNDROME	0.035714300000000004	1.7857150000000002
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2	0.035714300000000004	1.7857150000000002
MYELOMA, MULTIPLE	0.035714300000000004	1.7857150000000002
GIANT NEUTROPHIL LEUKOCYTES	0.035714300000000004	1.7857150000000002
MESOMELIA-SYNOSTOSES SYNDROME	0.035714300000000004	1.7857150000000002
BLUE DIAPER SYNDROME	0.035714300000000004	1.7857150000000002
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.035714300000000004	1.7857150000000002
SCLERODERMA, FAMILIAL PROGRESSIVE	0.035714300000000004	1.7857150000000002
AMYLOIDOSIS, FINNISH TYPE	0.035714300000000004	1.7857150000000002
PARANA HARD-SKIN SYNDROME	0.035714300000000004	1.7857150000000002
HEMOPOIETIC PROLIFERATION	0.035714300000000004	1.7857150000000002
TERATOMA, PINEAL	0.035714300000000004	1.7857150000000002
POLYPOSIS SYNDROME, HEREDITARY MIXED, 1	0.035714300000000004	1.7857150000000002
METHANE PRODUCTION	0.035714300000000004	1.7857150000000002
FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3	0.035714300000000004	1.7857150000000002
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.035714300000000004	1.7857150000000002
PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS	0.035714300000000004	1.7857150000000002
%243600 JEJUNAL ATRESIA;;APPLE PEEL SYNDROME;;APPLE PEEL SMALL BOWEL SYNDROME; APSB	0.035714300000000004	1.7857150000000002
ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS; ILVASC	0.035714300000000004	1.7857150000000002
GASTRIC SNEEZING	0.035714300000000004	1.7857150000000002
EOSINOPHILOPENIA	0.035714300000000004	1.7857150000000002
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.035714300000000004	1.7857150000000002
HEMOGLOBIN, HIGH OXYGEN SATURATION OF	0.035714300000000004	1.7857150000000002
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.035578581	1.77892905
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.035506641000000005	1.7753320500000003
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.03533163	1.7665815
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.035288942	1.7644471
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.035279201999999996	1.7639600999999998
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.035231002000000004	1.7615501000000002
IMMUNODEFICIENCY 10; IMD10	0.03509362	1.754681
AUTOINFLAMMATORY SYNDROME, FAMILIAL, BEHCET-LIKE	0.03509362	1.754681
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.03509293300000001	1.7546466500000004
OCULODENTODIGITAL DYSPLASIA; ODDD	0.034966871	1.7483435499999997
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.034832351	1.74161755
STROMME SYNDROME; STROMS	0.0348213	1.7410649999999999
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.03444689	1.7223445
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.03444689	1.7223445
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.03443532	1.721766
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.03443532	1.721766
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.034395262999999995	1.7197631499999997
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.034123223	1.70616115
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.034123223	1.70616115
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.034123222999999994	1.7061611499999998
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.034094621000000006	1.7047310500000004
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.03381709	1.6908545000000001
FAMILIAL MEDITERRANEAN FEVER; FMF	0.03381709	1.6908545000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.033754863	1.6877431500000002
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.033626663	1.68133315
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.0335738	1.67869
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.033375403	1.6687701499999998
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.0333333	1.666665
SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO	0.0333333	1.666665
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0333333	1.666665
DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF	0.0333333	1.666665
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS	0.0333333	1.666665
IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW	0.0333333	1.666665
SHORT SYNDROME	0.0333333	1.666665
#254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL;;LGM;;CONGENITAL MYASTHENIC SYNDROME TYPE Ib; CMS1B;;CMS Ib;;MYASTHENIC MYOPATHY, FORMERLY	0.0333333	1.666665
#246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3	0.0333333	1.666665
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0333333	1.666665
IMMUNE SUPPRESSION	0.0333333	1.666665
GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN	0.0333333	1.666665
SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS	0.0333333	1.666665
ECHO VIRUS 11 SENSITIVITY	0.0333333	1.666665
RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY	0.0333333	1.666665
METACHROMATIC LEUKODYSTROPHY	0.033279341	1.66396705
LETTERER-SIWE DISEASE	0.03320822	1.6604109999999999
PEROXISOME BIOGENESIS DISORDER 6B	0.033207472	1.6603736
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.033207472	1.6603736
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.033207471999999995	1.6603735999999998
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.033106703	1.65533515
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.033091800000000005	1.6545900000000002
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.033068102	1.6534051
TRANSALDOLASE DEFICIENCY	0.03281441	1.6407205
COFFIN-SIRIS SYNDROME 8; CSS8	0.032604041	1.63020205
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.032532282	1.6266141
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.032532282	1.6266141
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.032367603	1.6183801500000001
MENKES DISEASE	0.032332340999999994	1.6166170499999997
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.0323232	1.6161600000000003
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.032285022999999996	1.6142511499999999
FONTAINE PROGEROID SYNDROME; FPS	0.03227992	1.6139959999999998
MEGALENCEPHALY WITH DYSMYELINATION	0.032165751	1.60828755
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.032165751	1.60828755
Adrenoleukodystrophy	0.032165751	1.60828755
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.032165751	1.60828755
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.032099682000000004	1.6049841000000002
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.032093882	1.6046941
HYPOPHOSPHATASIA, INFANTILE	0.031981621	1.5990810500000001
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.031767102000000005	1.5883551000000002
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.031706203	1.5853101500000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.031694972	1.5847486000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.031694972	1.5847486000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.031694972	1.5847486000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.031694972	1.5847486000000002
MEIER-GORLIN SYNDROME 6; MGORS6	0.03158709	1.5793545
ADAMS-OLIVER SYNDROME 2; AOS2	0.031541853	1.57709265
HURLER SYNDROME	0.031430972	1.5715486
OSTEOPENIA AND SPARSE HAIR	0.031416589999999994	1.5708294999999997
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.03125	1.5625
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.03125	1.5625
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.03125	1.5625
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.03125	1.5625
#128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1;;PAROXYSMAL KINESIGENIC CHOREOATHETOSIS; PKC;;PAROXYSMAL KINESIGENIC DYSKINESIA; PKD;;DYSTONIA, FAMILIAL PAROXYSMAL;;DYSTONIA 10; DYT10	0.031218750999999996	1.5609375499999998
15q13.3 microdeletion syndrome	0.031218750999999996	1.5609375499999998
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.03121399	1.5606995000000001
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.031171433	1.55857165
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.031171433	1.55857165
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.031171433	1.55857165
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.031146881999999997	1.5573441
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.031146881999999997	1.5573441
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.031080740999999995	1.5540370499999998
OPTIC ATROPHY 11; OPA11	0.030960402	1.5480201
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.030941062999999998	1.54705315
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.030879501000000004	1.5439750500000002
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.030675333	1.53376665
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.030591501	1.52957505
HURLER-SCHEIE SYNDROME	0.030587089999999997	1.5293545
STUVE-WIEDEMANN SYNDROME	0.03052539	1.5262695
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.030414373	1.52071865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.030402972	1.5201486
XQ25 DUPLICATION SYNDROME	0.030386382999999996	1.5193191499999998
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.0303309	1.516545
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.0303309	1.516545
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.0303309	1.516545
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.030327550999999998	1.5163775499999999
DIMPLES, FACIAL	0.030302999999999997	1.5151499999999998
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.030302999999999997	1.5151499999999998
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.030302999999999997	1.5151499999999998
WAARDENBURG SYNDROME, TYPE IIB	0.030302999999999997	1.5151499999999998
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.030302999999999997	1.5151499999999998
NASAL GROOVE, FAMILIAL TRANSVERSE	0.030302999999999997	1.5151499999999998
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.030302999999999997	1.5151499999999998
SPEECH-LANGUAGE DISORDER 1	0.030302999999999997	1.5151499999999998
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.030302999999999997	1.5151499999999998
22q11.2 distal deletion syndrome	0.030302999999999997	1.5151499999999998
NASAL ALAR COLLAPSE, BILATERAL	0.030302999999999997	1.5151499999999998
EDINBURGH MALFORMATION SYNDROME	0.030302999999999997	1.5151499999999998
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.030302999999999997	1.5151499999999998
OROFACIAL CLEFT 3	0.030302999999999997	1.5151499999999998
NASAL BONES, ABSENCE OF	0.030302999999999997	1.5151499999999998
DWARFISM, LEVI TYPE	0.030302999999999997	1.5151499999999998
15q24 recurrent microdeletion syndrome	0.030302999999999997	1.5151499999999998
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.030302999999999997	1.5151499999999998
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.030302999999999997	1.5151499999999998
CLEFT CHIN	0.030302999999999997	1.5151499999999998
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.030302999999999997	1.5151499999999998
CYANIDE, INABILITY TO SMELL	0.030302999999999997	1.5151499999999998
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.030255682	1.5127841
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.030233661	1.51168305
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.030175682000000002	1.5087841000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.030156732000000002	1.5078366
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.030147553000000004	1.5073776500000002
#612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC;;COATS PLUS SYNDROME	0.029853371	1.49266855
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0297375	1.486875
#606367 IMMUNODEFICIENCY 41 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD41;;INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF;;IL2RA DEFICIENCY;;CD25 DEFICIENCY	0.02964669	1.4823344999999999
DOHLE BODIES AND LEUKEMIA	0.0294118	1.4705899999999998
#613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5	0.0294118	1.4705899999999998
IMMUNODEFICIENCY 9; IMD9	0.0294118	1.4705899999999998
Yao syndrome	0.0294118	1.4705899999999998
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.0294118	1.4705899999999998
MARSILI SYNDROME; MARSIS	0.0294118	1.4705899999999998
IMMUNODEFICIENCY 61; IMD61	0.0294118	1.4705899999999998
#134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT;;FMF, AUTOSOMAL DOMINANT	0.0294118	1.4705899999999998
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V	0.0294118	1.4705899999999998
PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT	0.0294118	1.4705899999999998
MAJEED SYNDROME	0.0294118	1.4705899999999998
PSEUDOTRISOMY 13 SYNDROME	0.029327640000000002	1.466382
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.029286033	1.46430165
KAPUR-TORIELLO SYNDROME	0.029242541000000004	1.46212705
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.028869371	1.44346855
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.028452072000000002	1.4226036000000002
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.028442151	1.42210755
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.028370282000000004	1.4185141000000001
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.028292423	1.41462115
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.028282799999999997	1.4141399999999997
HAREL-YOON SYNDROME; HAYOS	0.028273272000000002	1.4136636
MENTAL RETARDATION, X-LINKED 41	0.028273272000000002	1.4136636
GLYCOGEN STORAGE DISEASE II	0.02822478	1.4112390000000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.028204693	1.41023465
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.02813259	1.4066295
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.02813259	1.4066295
#235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1;;AHUS, SUSCEPTIBILITY TO, 1HEMOLYTIC UREMIC SYNDROME, TYPICAL, INCLUDED	0.028106191	1.40530955
ADAMS-OLIVER SYNDROME 5; AOS5	0.028048340999999997	1.40241705
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.027755781	1.38778905
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.027755781	1.38778905
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.027676232999999998	1.38381165
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.027666233	1.38331165
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.027639221000000002	1.3819610500000001
ASPARTYLGLUCOSAMINURIA; AGU	0.027444271	1.37221355
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.027400633000000004	1.3700316500000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.027338482	1.3669241
CHITAYAT SYNDROME	0.027295389999999996	1.3647694999999997
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.027288942	1.3644471
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.027277953000000004	1.3638976500000002
IMMUNODEFICIENCY 23; IMD23	0.027198872000000002	1.3599436
WEBB-DATTANI SYNDROME; WEDAS	0.027178833	1.35894165
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.027155412	1.3577706
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.027132589999999998	1.3566295
IMMUNODEFICIENCY 32B; IMD32B	0.02711119	1.3555595
#615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEGSPASTICITY; HBSL;;ASPARTYL-tRNA SYNTHETASE DEFICIENCY	0.02684003	1.3420015
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.026802153	1.34010765
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.026654340999999998	1.3327170499999998
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.02664201	1.3321005000000001
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.02664201	1.3321005000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.026563323000000003	1.3281661500000002
#609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3	0.0264946	1.32473
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.0264946	1.32473
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.0263158	1.31579
#612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5	0.0263158	1.31579
MYOCLONIC-ATONIC EPILEPSY	0.0263158	1.31579
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.026307523	1.31537615
PSEUDO-TORCH SYNDROME 2	0.026278791	1.31393955
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.026129023	1.30645115
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.026129023	1.30645115
POPOV-CHANG SYNDROME; POPCHAS	0.025828401999999997	1.2914200999999998
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.02571211	1.2856055
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.025688252999999998	1.28441265
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.025670252	1.2835126000000001
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.025670252	1.2835126000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.025665431	1.28327155
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.025641000000000004	1.2820500000000001
CEREBROOCULONASAL SYNDROME	0.02561615	1.2808075
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.025600523	1.28002615
TIMOTHY SYNDROME; TS	0.025600523	1.28002615
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.025579123000000002	1.2789561500000002
SECKEL SYNDROME 1; SCKL1	0.025551841	1.27759205
FIBROCHONDROGENESIS 1; FBCG1	0.02552842	1.276421
LOEYS-DIETZ SYNDROME 5	0.02552842	1.276421
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.025504303000000002	1.2752151500000002
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.025403531	1.27017655
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.025403531	1.27017655
#614162 IMMUNODEFICIENCY 31C; IMD31C;;CANDIDIASIS, FAMILIAL, 7; CANDF7;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL DOMINANT	0.0252414	1.26207
IMMUNODEFICIENCY 50; IMD50	0.0252414	1.26207
#615607 IMMUNODEFICIENCY 17; IMD17;;CD3-GAMMA DEFICIENCY;;SCID-LIKE IMMUNODEFICIENCY, T CELL-PARTIAL, B CELL-POSITIVE, NK CELL-POSITIVE	0.0252414	1.26207
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.025206613000000003	1.2603306500000002
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.025095423000000002	1.25477115
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.025015433	1.25077165
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.025015433	1.25077165
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.024844371	1.24221855
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.024844371	1.24221855
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.024684772	1.2342386
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.024684772	1.2342386
HADZISELIMOVIC SYNDROME	0.024622131999999998	1.2311066
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.024558453	1.22792265
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.024486933	1.22434665
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.024479972	1.2239986
COFFIN-SIRIS SYNDROME 5	0.024424293	1.22121465
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.024409602	1.2204800999999998
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.024336282	1.2168141000000001
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.024336161	1.21680805
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.024171551	1.20857755
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.024171551	1.20857755
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.024171551	1.20857755
#125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTSAND LEUKOENCEPHALOPATHY; CADASIL;;DEMENTIA, HEREDITARY MULTI-INFARCT TYPE;;CASIL	0.024171551	1.20857755
OROFACIODIGITAL SYNDROME VI	0.023989392000000002	1.1994696
EMANUEL SYNDROME	0.023944373	1.1972186500000002
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.02384089	1.1920445
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.02384089	1.1920445
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.02377825	1.1889125
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.023730781	1.18653905
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.023711912999999998	1.1855956499999998
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.023711912999999998	1.1855956499999998
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.023659193	1.18295965
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.023658911999999997	1.1829455999999998
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.02363609	1.1818045
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.023625	1.18125
ROIFMAN SYNDROME; RFMN	0.023604162	1.1802081
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.023579621000000002	1.1789810500000002
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.023434299999999998	1.1717149999999998
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.023434299999999998	1.1717149999999998
ACROMICRIC DYSPLASIA	0.023434299999999998	1.1717149999999998
EPILEPSY, HOT WATER, 1	0.023335790000000002	1.1667895000000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.023296012	1.1648006
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.02327319	1.1636595
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.0232558	1.16279
LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY	0.0232558	1.16279
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	0.0232558	1.16279
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0232558	1.16279
#615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT	0.0232558	1.16279
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.0232558	1.16279
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.023066082	1.1533041000000002
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.023066082	1.1533041000000002
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02294953	1.1474765
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.02294953	1.1474765
GRANULOMAS, CONGENITAL CEREBRAL	0.02294953	1.1474765
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02294953	1.1474765
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02294953	1.1474765
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02294953	1.1474765
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.02292322	1.146161
IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED; IPEX	0.02292322	1.146161
#301000 WISKOTT-ALDRICH SYNDROME; WAS;;WISKOTT-ALDRICH SYNDROME 1; WAS1;;ALDRICH SYNDROME;;ECZEMA-THROMBOCYTOPENIA-IMMUNODEFICIENCY SYNDROME;;IMMUNODEFICIENCY 2; IMD2	0.02292322	1.146161
#614493 WISKOTT-ALDRICH SYNDROME 2; WAS2;;WIPF1 DEFICIENCY	0.02292322	1.146161
BLEEDING DISORDER, PLATELET-TYPE, 21; BDPLT21	0.02292322	1.146161
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.022868030999999997	1.1434015499999999
FRONTONASAL DYSPLASIA 2; FND2	0.02281503	1.1407515
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.022743441999999996	1.1371720999999997
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.0227273	1.1363649999999998
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.0227273	1.1363649999999998
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0227273	1.1363649999999998
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.0227273	1.1363649999999998
#611363 ATRIAL SEPTAL DEFECT 4; ASD4	0.0227273	1.1363649999999998
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.0227273	1.1363649999999998
STING-ASSOCIATED VASCULOPATHY, INFANTILE-ONSET; SAVI	0.0227059	1.1352950000000002
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.022681780999999998	1.1340890499999998
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.022681780999999998	1.1340890499999998
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.022681780999999998	1.1340890499999998
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.022678852	1.1339426
MECKEL SYNDROME, TYPE 1; MKS1	0.02259996	1.1299979999999998
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.02258554	1.129277
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.02253602	1.126801
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.02246692	1.1233460000000002
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.022424371	1.12121855
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.022263429999999997	1.1131714999999998
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.0222222	1.11111
MENTAL RETARDATION, X-LINKED 77	0.0222222	1.11111
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.0222222	1.11111
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.0222222	1.11111
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.0222222	1.11111
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.022151860000000002	1.107593
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.022104023	1.10520115
ADENYLOSUCCINASE DEFICIENCY	0.022104023	1.10520115
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.022104023	1.10520115
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.022104023	1.10520115
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.022082453000000002	1.10412265
ZECHI-CEIDE SYNDROME	0.02203192	1.101596
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.02203192	1.101596
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.021952279999999998	1.0976139999999999
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.021939220000000002	1.096961
GLYCINE ENCEPHALOPATHY; GCE	0.021892091000000002	1.0946045500000001
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.021778732999999998	1.08893665
HYPERPROLINEMIA, TYPE I	0.021741123	1.08705615
HYPERCALCEMIA, INFANTILE, 1	0.02169327	1.0846635
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.021669512000000002	1.0834756
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.02166902	1.083451
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.02164669	1.0823345
CASPASE 8 DEFICIENCY	0.02164669	1.0823345
NOONAN SYNDROME 5; NS5	0.021629851999999998	1.0814925999999998
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.021629851999999998	1.0814925999999998
BAND HETEROTOPIA; BH	0.021622383000000002	1.0811191500000001
NIEMANN-PICK DISEASE, TYPE A	0.021609141999999998	1.0804570999999998
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.02150862	1.075431
STIFF-PERSON SYNDROME; SPS	0.02150862	1.075431
CIRRHOSIS, FAMILIAL	0.02150862	1.075431
ENDOCARDIAL FIBROELASTOSIS	0.02147207	1.0736035
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.021440853000000003	1.0720426500000002
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.021375543000000004	1.0687771500000003
DERMATITIS, ATOPIC	0.02132303	1.0661515
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.021260141	1.06300705
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.021260141	1.06300705
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.021260141	1.06300705
JOUBERT SYNDROME 6	0.021188272	1.0594136
JOUBERT SYNDROME 35; JBTS35	0.021188272	1.0594136
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.02118047	1.0590235
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.021166702	1.0583350999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.021055023	1.05275115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.021055023	1.05275115
TEMPLE-BARAITSER SYNDROME; TMBTS	0.021055023	1.05275115
PETTIGREW SYNDROME	0.021055023	1.05275115
PITT-HOPKINS SYNDROME	0.021038241000000003	1.05191205
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.020990433	1.04952165
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.020990433	1.04952165
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.020989202999999998	1.0494601499999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.020825372	1.0412686
RING CHROMOSOME 14 SYNDROME	0.020825372	1.0412686
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.020825372	1.0412686
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.020768533000000002	1.0384266500000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.020767931	1.03839655
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.020737413	1.03687065
CURRY-JONES SYNDROME	0.020706632000000003	1.0353316000000001
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.020689452	1.0344726
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.020629233	1.03146165
JOUBERT SYNDROME 24	0.020525102000000003	1.0262551000000002
#274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP;;MICROANGIOPATHIC HEMOLYTIC ANEMIA;;THROMBOTIC MICROANGIOPATHY, FAMILIAL;;UPSHAW-SCHULMAN SYNDROME; USS;;SCHULMAN-UPSHAW SYNDROME;;UPSHAW FACTOR, DEFICIENCY OF;;MICROANGIOPATHIC HEMOLYTIC ANEMIA, CONGENITAL;;THROMBOTIC THROMBOCYTOPENIC PURPURA, FAMILIAL	0.020387719999999998	1.019386
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.020387719999999998	1.019386
JOUBERT SYNDROME 4	0.02034439	1.0172195
JOUBERT SYNDROME 3; JBTS3	0.02034439	1.0172195
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.020327263	1.01636315
MARDEN-WALKER SYNDROME	0.020224011	1.01120055
NOONAN SYNDROME 7; NS7	0.020211141	1.0105570499999998
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.020146551	1.0073275499999998
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.020146551	1.0073275499999998
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.020146551	1.0073275499999998
SECKEL SYNDROME 7; SCKL7	0.020146551	1.0073275499999998
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.020139272	1.0069636
SULFOCYSTEINURIA	0.020114622999999998	1.00573115
WARBURG MICRO SYNDROME 1	0.020091369999999997	1.0045685
JOUBERT SYNDROME 17; JBTS17	0.020074682	1.0037341
300270 ADRENOMYODYSTROPHY	0.020074682	1.0037341
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.020016473	1.00082365
ZIMMERMANN-LABAND SYNDROME 1	0.019767931	0.9883965499999999
BETA-UREIDOPROPIONASE DEFICIENCY	0.019711782	0.9855891
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.019711782	0.9855891
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.019711782	0.9855891
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.019711782	0.9855891
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.01961591	0.9807955
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.019603892	0.9801946
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.019526790000000002	0.9763395000000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.019483381	0.9741690500000001
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.019411512000000002	0.9705756000000001
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.019411512000000002	0.9705756000000001
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.01930826	0.9654130000000001
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.01929539	0.9647695
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.01929539	0.9647695
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.0192308	0.96154
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.0192308	0.96154
ALLAN-HERNDON-DUDLEY SYNDROME	0.0192308	0.96154
#614844 NEPHRONOPHTHISIS 14; NPHP14JOUBERT SYNDROME 19, INCLUDED; JBTS19, INCLUDED	0.0192308	0.96154
#612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C	0.0192308	0.96154
LEBER CONGENITAL AMAUROSIS, TYPE II	0.0192308	0.96154
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.0192308	0.96154
JOUBERT SYNDROME 13; JBTS13	0.0192308	0.96154
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.0192308	0.96154
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.0192308	0.96154
ANTERIOR SEGMENT DYSGENESIS 3	0.0192308	0.96154
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01920923	0.9604615000000001
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.01911119	0.9555595
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.01911119	0.9555595
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.01911119	0.9555595
AUTOINFLAMMATION WITH INFANTILE ENTEROCOLITIS; AIFEC	0.01911119	0.9555595
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.01911119	0.9555595
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.01911119	0.9555595
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY	0.01911119	0.9555595
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.01911119	0.9555595
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.019107013	0.95535065
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.019107013	0.95535065
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.019097550999999997	0.9548775499999999
THAUVIN-ROBINET-FAIVRE SYNDROME	0.019025682	0.9512841
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.019025682	0.9512841
ALAZAMI SYNDROME; ALAZS	0.019025682	0.9512841
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.019025682	0.9512841
Retinitis pigmentosa with or without skeletal anomalies	0.019025682	0.9512841
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.019001033	0.95005165
CHROMOSOME 2q37 DELETION SYNDROME	0.019001033	0.95005165
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.018946870999999997	0.9473435499999998
ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD	0.0188679	0.943395
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.943395
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.943395
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.943395
269800 SENILE PLAQUE FORMATION	0.0188679	0.943395
JUMPING FRENCHMAN OF MAINE	0.0188679	0.943395
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.943395
THUMBS, CONGENITAL CLASPED	0.0188679	0.943395
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.943395
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0188679	0.943395
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.943395
DIASTEMATOMYELIA	0.0188679	0.943395
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.943395
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.943395
MOTION SICKNESS	0.0188679	0.943395
PALMOMENTAL REFLEX	0.0188679	0.943395
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	0.943395
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.943395
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.943395
CARDIAC ARRHYTHMIA	0.0188679	0.943395
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0188679	0.943395
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.943395
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.943395
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0188679	0.943395
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.943395
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.943395
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.943395
#614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3	0.0188679	0.943395
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.943395
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.943395
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.943395
CERVICAL RIB	0.0188679	0.943395
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.943395
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0188679	0.943395
ALCOHOL DEPENDENCE	0.0188679	0.943395
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.943395
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.943395
ERYTHERMALGIA, PRIMARY	0.0188679	0.943395
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.943395
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.943395
MYOPATHY, CONGENITAL	0.0188679	0.943395
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.943395
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.943395
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0188679	0.943395
RECOMBINANT CHROMOSOME 8 SYNDROME	0.018810693	0.94053465
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01878753	0.9393765000000001
MEIER-GORLIN SYNDROME 1; MGORS1	0.01873859	0.9369295
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.018654340999999998	0.9327170499999999
MUCOPOLYSACCHARIDOSIS, TYPE II	0.018654340999999998	0.9327170499999999
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.018630643	0.9315321499999999
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.01856763	0.9283815000000001
LYSINURIC PROTEIN INTOLERANCE; LPI	0.018447079999999998	0.9223539999999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.018434071000000003	0.9217035500000001
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.018376363	0.91881815
GAPO SYNDROME; GAPOS	0.018330680999999998	0.9165340499999999
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.018330680999999998	0.9165340499999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.018290129999999998	0.9145064999999999
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.01825684	0.912842
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.018181799999999998	0.90909
FEINGOLD SYNDROME 1; FGLDS1	0.018181799999999998	0.90909
THREE M SYNDROME 2; 3M2	0.018181799999999998	0.90909
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.018181799999999998	0.90909
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.018181799999999998	0.90909
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.018181799999999998	0.90909
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.018181799999999998	0.90909
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.018181799999999998	0.90909
MEIER-GORLIN SYNDROME 8; MGORS8	0.018181799999999998	0.90909
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.018181799999999998	0.90909
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.018181799999999998	0.90909
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.018164363000000003	0.9082181500000002
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.018164363000000003	0.9082181500000002
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.018164363000000003	0.9082181500000002
LISSENCEPHALY 8; LIS8	0.018164363000000003	0.9082181500000002
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.018164363000000003	0.9082181500000002
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.018157151	0.90785755
PHENYLKETONURIA	0.018157151	0.90785755
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.018133243	0.9066621500000001
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.018119602999999998	0.9059801499999999
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.018059000999999998	0.90295005
PRIMROSE SYNDROME; PRIMS	0.018031119999999998	0.9015559999999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.018018860999999997	0.9009430499999999
CRANIOFRONTONASAL SYNDROME; CFNS	0.017989242	0.8994620999999999
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.017987132000000003	0.8993566000000002
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.017785463	0.8892731500000001
DIAPHANOSPONDYLODYSOSTOSIS	0.017579092	0.8789546
OROFACIODIGITAL SYNDROME I; OFD1	0.017561840999999998	0.8780920499999999
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.017532481	0.87662405
JACOBSEN SYNDROME	0.017399579999999998	0.8699789999999998
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.017327053000000002	0.8663526500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.017327053000000002	0.8663526500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.017327053000000002	0.8663526500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.017327053000000002	0.8663526500000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.017327053000000002	0.8663526500000001
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.017320481000000002	0.8660240500000002
WARBURG MICRO SYNDROME 3; WARBM3	0.017320481000000002	0.8660240500000002
#615937 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 2;MPPH2	0.017320481000000002	0.8660240500000002
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.017289361	0.8644680499999999
CORNELIA DE LANGE SYNDROME 3	0.017265923000000002	0.8632961500000002
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.017248612000000003	0.8624306000000002
PROTOPORPHYRIA, ERYTHROPOIETIC	0.0172414	0.86207
ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD	0.0172414	0.86207
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.0172414	0.86207
PORPHYRIA CUTANEA TARDA, TYPE I	0.0172414	0.86207
NEUTROPHIL CHEMOTACTIC RESPONSE	0.0172414	0.86207
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.0172414	0.86207
MYCOSIS FUNGOIDES	0.0172414	0.86207
IGE RESPONSIVENESS, ATOPIC	0.0172414	0.86207
BLAU SYNDROME	0.0172414	0.86207
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.0172414	0.86207
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.0172414	0.86207
IMMUNODEFICIENCY 55; IMD55	0.0172414	0.86207
POLYGLUCOSAN BODY MYOPATHY 1 WITH OR WITHOUT IMMUNODEFICIENCY; PGBM1	0.0172414	0.86207
MENTAL RETARDATION, X-LINKED 103	0.017184303	0.85921515
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.017133282	0.8566640999999999
OCULOCEREBROCUTANEOUS SYNDROME	0.016947521	0.84737605
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.016947521	0.84737605
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.01691753	0.8458765
GAUCHER DISEASE, TYPE I	0.016889829999999998	0.8444915
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.0167868	0.8393400000000001
ELSAHY-WATERS SYNDROME; ESWS	0.016781352	0.8390675999999999
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.016735240999999998	0.8367620499999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.016645959999999998	0.8322979999999999
BARAITSER-WINTER SYNDROME 1; BRWS1	0.016601273	0.83006365
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.016558453	0.8279226500000001
DESANTO-SHINAWI SYNDROME	0.016558453	0.8279226500000001
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.016540751	0.82703755
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.016540751	0.82703755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.016483171	0.82415855
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.016483171	0.82415855
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.016468882	0.8234441
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016468882	0.8234441
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016468882	0.8234441
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.016468882	0.8234441
ROIFMAN-CHITAYAT SYNDROME	0.016468882	0.8234441
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016468882	0.8234441
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.016468882	0.8234441
ANIRIDIA	0.016404730000000003	0.8202365000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.016346993	0.81734965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.016346993	0.81734965
BOHRING-OPITZ SYNDROME	0.016300823	0.81504115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.016213463	0.8106731500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.016213463	0.8106731500000001
Helsmoortel-van der Aa syndrome	0.016206523	0.8103261500000001
MEIER-GORLIN SYNDROME 3; MGORS3	0.01593747	0.7968734999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.01593747	0.7968734999999999
MACS SYNDROME	0.01593747	0.7968734999999999
CRI-DU-CHAT SYNDROME	0.01593747	0.7968734999999999
NOONAN SYNDROME 4; NS4	0.01593747	0.7968734999999999
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.01593747	0.7968734999999999
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.015802442	0.7901221
METHYLMALONIC ACIDURIA, CBLA TYPE	0.015801423000000002	0.79007115
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.015801423000000002	0.79007115
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.015714571	0.78572855
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.015693723000000003	0.7846861500000002
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.015693723000000003	0.7846861500000002
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.015693723000000003	0.7846861500000002
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.015693723000000003	0.7846861500000002
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.015693723000000003	0.7846861500000002
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.015693723000000003	0.7846861500000002
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.015693723000000003	0.7846861500000002
HOLOPROSENCEPHALY 1; HPE1	0.015662602999999997	0.7831301499999999
HOLOPROSENCEPHALY 2; HPE2	0.015662602999999997	0.7831301499999999
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.015642702	0.7821351000000001
HYDROXYLYSINURIA	0.015625	0.78125
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.015625	0.78125
PAINE SYNDROME	0.015625	0.78125
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.015625	0.78125
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.015625	0.78125
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.015625	0.78125
CARNOSINEMIA	0.015625	0.78125
#614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11	0.015625	0.78125
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.015625	0.78125
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.015621650999999999	0.7810825499999999
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.015621650999999999	0.7810825499999999
#141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1;;FHM;;MHP1MIGRAINE, FAMILIAL HEMIPLEGIC 1, WITH PROGRESSIVE CEREBELLAR ATAXIA,INCLUDED;;MIGRAINE, SPORADIC HEMIPLEGIC, INCLUDED	0.015621650999999999	0.7810825499999999
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.015621650999999999	0.7810825499999999
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.015621620000000003	0.7810810000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.015578393000000001	0.7789196500000001
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.015578393000000001	0.7789196500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.015567419999999998	0.7783709999999999
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.015549782	0.7774891
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.015549782	0.7774891
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.015444863	0.77224315
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.015290772	0.7645386
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.015290772	0.7645386
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.015290772	0.7645386
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.015259990999999997	0.7629995499999999
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.01524638	0.762319
MICROPHTHALMIA, SYNDROMIC 3	0.015188121999999998	0.7594060999999999
MENTAL RETARDATION, X-LINKED 9	0.015092933	0.75464665
EPISODIC ATAXIA, TYPE 6	0.015022851	0.75114255
#170100 PROLIDASE DEFICIENCY	0.015012622	0.7506311
ZTTK SYNDROME; ZTTKS	0.015005702999999999	0.75028515
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.014964851000000001	0.7482425500000001
Fabry disease	0.014964851000000001	0.7482425500000001
MARSHALL-SMITH SYNDROME; MRSHSS	0.01495856	0.7479279999999999
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.014885671999999999	0.7442835999999999
METHYLMALONIC ACIDURIA, CBLB TYPE	0.014885671999999999	0.7442835999999999
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.014877002	0.7438501
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.014859592000000001	0.7429796000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.014849841	0.7424920500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.014849841	0.7424920500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.014849841	0.7424920500000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.014849841	0.7424920500000001
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.014849841	0.7424920500000001
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.014818720999999998	0.74093605
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.014777972000000002	0.7388986000000001
JOUBERT SYNDROME 32; JBTS32	0.014777972000000002	0.7388986000000001
COCKAYNE SYNDROME A; CSA	0.014727931	0.73639655
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3	0.0147059	0.7352949999999999
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.0147059	0.7352949999999999
DYSTONIA 12; DYT12	0.0147059	0.7352949999999999
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.0147059	0.7352949999999999
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.0147059	0.7352949999999999
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.0147059	0.7352949999999999
PSEUDODIASTROPHIC DYSPLASIA	0.0147059	0.7352949999999999
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 4; FCAS4	0.0147059	0.7352949999999999
PSORIASIS 14, PUSTULAR	0.0147059	0.7352949999999999
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.0147059	0.7352949999999999
HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES	0.0147059	0.7352949999999999
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.0147059	0.7352949999999999
#145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1;;MHS;;HYPERTHERMIA OF ANESTHESIA;;HYPERPYREXIA, MALIGNANT; MHKING SYNDROME, INCLUDED;;KING-DENBOROUGH SYNDROME, INCLUDED	0.0147059	0.7352949999999999
MYOCLONIC EPILEPSY, JUVENILE, 2	0.0147059	0.7352949999999999
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.0147059	0.7352949999999999
#104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1	0.0147059	0.7352949999999999
PANCREATITIS, HEREDITARY	0.0147059	0.7352949999999999
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.0147059	0.7352949999999999
NEUROPATHY, PAINFUL	0.0147059	0.7352949999999999
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.0147059	0.7352949999999999
CINCA SYNDROME; CINCA	0.0147059	0.7352949999999999
#608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3;;HPLH3;;HLH3	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2	0.0147059	0.7352949999999999
CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0147059	0.7352949999999999
NEUROPATHY, HEREDITARY THERMOSENSITIVE	0.0147059	0.7352949999999999
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.0147059	0.7352949999999999
MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5	0.0147059	0.7352949999999999
RHABDOMYOLYSIS, ACUTE RECURRENT	0.0147059	0.7352949999999999
#607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2;;BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY 2; BAFME2;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 2; FCMTE2;;CORTICAL MYOCLONUS AND EPILEPSY, AUTOSOMAL DOMINANT; ADCME	0.0147059	0.7352949999999999
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.0147059	0.7352949999999999
CAFFEY DISEASE	0.0147059	0.7352949999999999
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0147059	0.7352949999999999
EPILEPSY, BENIGN NEONATAL, 3	0.0147059	0.7352949999999999
FEVER, FAMILIAL LIFELONG PERSISTENT	0.0147059	0.7352949999999999
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.014687833	0.7343916500000001
GLASS SYNDROME	0.014661753	0.73308765
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.014580133000000002	0.7290066500000001
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.014580133000000002	0.7290066500000001
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.014580133000000002	0.7290066500000001
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.014580133000000002	0.7290066500000001
HYPEREKPLEXIA 4; HKPX4	0.014580133000000002	0.7290066500000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.014580133000000002	0.7290066500000001
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.014580133000000002	0.7290066500000001
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.014549013	0.72745065
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.014549013	0.72745065
LISSENCEPHALY 4	0.014549013	0.72745065
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.014549013	0.72745065
GABA-TRANSAMINASE DEFICIENCY	0.014549013	0.72745065
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.014529112	0.7264556
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.014524893	0.72624465
MENTAL RETARDATION, X-LINKED 19	0.014446889999999999	0.7223445
CLARK-BARAITSER SYNDROME	0.014249050999999999	0.71245255
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.014249050999999999	0.71245255
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.014249050999999999	0.71245255
FOUNTAIN SYNDROME	0.014249050999999999	0.71245255
ATKIN-FLAITZ SYNDROME	0.014249050999999999	0.71245255
PETERS-PLUS SYNDROME; PTRPLS	0.014207173	0.71035865
COSTELLO SYNDROME; CSTLO	0.014177182	0.7088591
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.014177182	0.7088591
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.014177182	0.7088591
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.014177182	0.7088591
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.0140491	0.702455
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.0140491	0.702455
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.01403312	0.701656
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.013934090000000001	0.6967045000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.013934090000000001	0.6967045000000001
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 2; CEMCOX2	0.013934090000000001	0.6967045000000001
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.013843951	0.69219755
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.01381876	0.6909379999999999
RENPENNING SYNDROME 1; RENS1	0.013817871	0.6908935500000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.013742823	0.68714115
RAYNAUD-CLAES SYNDROME; MRXSRC	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.013742823	0.68714115
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.013742823	0.68714115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.013742823	0.68714115
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.013742823	0.68714115
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.013742823	0.68714115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.013742823	0.68714115
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.013736251000000001	0.6868125500000001
CROME SYNDROME	0.013736251000000001	0.6868125500000001
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.013736251000000001	0.6868125500000001
KNOBLOCH SYNDROME 1; KNO1	0.013736251000000001	0.6868125500000001
#608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3;;ENCEPHALOPATHY, ACUTE NECROTIZING, SUSCEPTIBILITY TO; ANE	0.013736251000000001	0.6868125500000001
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.013736251000000001	0.6868125500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.013736251000000001	0.6868125500000001
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.013736251000000001	0.6868125500000001
CHROMOSOME 13q14 DELETION SYNDROME	0.01368523	0.6842615
IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6	0.01368182	0.684091
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.013664382000000003	0.6832191000000001
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.013664382000000003	0.6832191000000001
CRANIOTELENCEPHALIC DYSPLASIA	0.013633262	0.6816631
GALACTOSE EPIMERASE DEFICIENCY	0.013609142000000001	0.6804571
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.013549052	0.6774526000000001
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.013549052	0.6774526000000001
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.013499702999999998	0.6749851499999999
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.013499702999999998	0.6749851499999999
PRADER-WILLI SYNDROME; PWS	0.013477392999999999	0.67386965
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.01340529	0.6702645
PREECLAMPSIA/ECLAMPSIA 1	0.013400291	0.67001455
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.013400291	0.67001455
FRYNS SYNDROME; FRNS	0.013363291	0.66816455
Xq28 (MECP2) duplication	0.013343863000000001	0.66719315
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.0133333	0.666665
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0133333	0.666665
PROGNATHISM, MANDIBULAR	0.0133333	0.666665
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.0133333	0.666665
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.0133333	0.666665
#611554 LEOPARD SYNDROME 2	0.0133333	0.666665
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.013291422	0.6645711000000001
HARTSFIELD SYNDROME; HRTFDS	0.013291422	0.6645711000000001
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.013260173	0.66300865
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.013249172	0.6624586
Myhre syndrome	0.013123761	0.65618805
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.01304912	0.652456
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.012974223	0.64871115
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.012960333000000001	0.6480166500000001
AICARDI-GOUTIERES SYNDROME 7	0.012960333000000001	0.6480166500000001
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.01290212	0.645106
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.01290212	0.645106
260150 PALANT CLEFT PALATE SYNDROME	0.01290212	0.645106
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.01290212	0.645106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.012898940999999999	0.64494705
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.012898940999999999	0.64494705
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6	0.012820500000000002	0.6410250000000001
#606688 SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES	0.012820500000000002	0.6410250000000001
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.012820500000000002	0.6410250000000001
IMMUNODEFICIENCY 44	0.012820500000000002	0.6410250000000001
#218800 CRIGLER-NAJJAR SYNDROME, TYPE I;;HYPERBILIRUBINEMIA, CRIGLER-NAJJAR TYPE I; HBLRCN1;;CRIGLER-NAJJAR SYNDROME	0.012820500000000002	0.6410250000000001
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.012820500000000002	0.6410250000000001
MECKEL SYNDROME 12; MKS12	0.01278938	0.639469
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.01270517	0.6352585
OROFACIAL CLEFT 15	0.01270517	0.6352585
VELOCARDIOFACIAL SYNDROME	0.01270517	0.6352585
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.012701983	0.6350991500000001
KLEEFSTRA SYNDROME	0.012633510999999998	0.6316755499999999
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.012629233	0.63146165
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.012629233	0.63146165
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.012583951999999999	0.6291975999999999
#612924 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4;;AHUS, SUSCEPTIBILITY TO, 4	0.012484539999999999	0.624227
#612925 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5;;AHUS, SUSCEPTIBILITY TO, 5	0.012484539999999999	0.624227
#612922 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2;;AHUS, SUSCEPTIBILITY TO, 2	0.012484539999999999	0.624227
ALPORT SYNDROME, X-LINKED; ATS	0.012484539999999999	0.624227
#612926 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6;;AHUS, SUSCEPTIBILITY TO, 6	0.012484539999999999	0.624227
#612923 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3;;AHUS, SUSCEPTIBILITY TO, 3	0.012484539999999999	0.624227
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.01244754	0.622377
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.01244754	0.622377
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.01244754	0.622377
FOCAL DERMAL HYPOPLASIA; FDH	0.01244754	0.622377
IMMUNODEFICIENCY 63 WITH LYMPHOPROLIFERATION AND AUTOIMMUNITY; IMD63	0.01240529	0.6202645
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.012272832	0.6136416
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.012204583000000001	0.6102291500000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.012204582999999998	0.6102291499999999
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.012204582999999998	0.6102291499999999
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.012204582999999998	0.6102291499999999
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.012130341000000001	0.60651705
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.012130341000000001	0.60651705
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.01208163	0.6040814999999999
NOONAN SYNDROME 11; NS11	0.012058472	0.6029236
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.012058472	0.6029236
LAMB-SHAFFER SYNDROME	0.012058472	0.6029236
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.012058472	0.6029236
%300712 CRANIOFACIOSKELETAL SYNDROME	0.011996301999999999	0.5998150999999999
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.01198319	0.5991595
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.011862742999999999	0.5931371499999999
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.011860633	0.59303165
GAUCHER DISEASE, TYPE II	0.011846743	0.59233715
#300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8;;HYPEREKPLEXIA AND EPILEPSY	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.011785351	0.58926755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.011785351	0.58926755
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.011713482	0.5856741000000001
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.011675760999999998	0.5837880499999999
HYPERLIPOPROTEINEMIA, TYPE I	0.01165167	0.5825834999999999
HYPER-IGD SYNDROME	0.01165167	0.5825834999999999
LYSOSOMAL ACID LIPASE DEFICIENCY	0.01165167	0.5825834999999999
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.011470362000000001	0.5735181
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.01142895	0.5714475
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.011406053	0.5703026499999999
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.011406053	0.5703026499999999
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.011360701	0.56803505
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.011288831999999999	0.5644415999999999
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.011224523	0.56122615
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.011224523	0.56122615
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.01121459	0.5607295
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.01121459	0.5607295
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.01121459	0.5607295
#133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1;;POLYCYTHEMIA, PRIMARY FAMILIAL AND CONGENITAL; PFCP;;ERYTHROCYTOSIS, AUTOSOMAL DOMINANT BENIGN	0.011208010000000001	0.5604005000000001
SICKLE CELL ANEMIA	0.011208010000000001	0.5604005000000001
AMYLOIDOSIS, FAMILIAL VISCERAL	0.011208010000000001	0.5604005000000001
THROMBOCYTHEMIA, ESSENTIAL	0.011208010000000001	0.5604005000000001
TRIMETHYLAMINURIA	0.011208010000000001	0.5604005000000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.011159213	0.55796065
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.01115242	0.557621
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.01112388	0.556194
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.01112388	0.556194
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.01112388	0.556194
611961 STEVENSON-CAREY SYNDROME	0.011090993	0.55454965
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.011090993	0.55454965
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.011090992999999999	0.5545496499999999
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.011025682999999998	0.5512841499999999
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.011018861000000001	0.5509430500000001
GAUCHER DISEASE, PERINATAL LETHAL	0.011002861	0.55014305
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.011002861	0.55014305
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.010944882000000001	0.5472441
DYSTONIA 28, CHILDHOOD-ONSET	0.010944882000000001	0.5472441
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.010944882000000001	0.5472441
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.010930992	0.5465496000000001
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.01092417	0.5462085
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.010884350000000001	0.5442175
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.010873223	0.5436611499999999
MELNICK-NEEDLES SYNDROME	0.01080112	0.5400560000000001
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.010760009999999999	0.5380004999999999
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.010749153000000001	0.53745765
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.010749153000000001	0.53745765
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.010687252000000001	0.5343626
HOLOPROSENCEPHALY 11	0.010687252000000001	0.5343626
REVESZ SYNDROME	0.010672642	0.5336320999999999
#615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11	0.01060417	0.5302085
MARTSOLF SYNDROME	0.01060417	0.5302085
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.010562170999999999	0.5281085499999999
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.010562170999999999	0.5281085499999999
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.010539083000000001	0.52695415
JOUBERT SYNDROME 26	0.010505721999999999	0.5252861
SMITH-KINGSMORE SYNDROME; SKS	0.010315331	0.51576655
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.010308771999999999	0.5154386
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.010246553	0.51232765
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.010243461999999998	0.5121730999999999
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.010175242	0.5087621
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.010175242	0.5087621
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.010175242	0.5087621
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.010119603000000001	0.5059801500000001
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.010119603000000001	0.5059801500000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.010119603000000001	0.5059801500000001
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.010119603000000001	0.5059801500000001
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.010119603000000001	0.5059801500000001
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.010119603000000001	0.5059801500000001
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.010110932999999999	0.50554665
NOSE, ANOMALOUS SHAPE OF	0.010101	0.50505
CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB	0.010101	0.50505
#608980 BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	0.010101	0.50505
15q26 overgrowth syndrome	0.010101	0.50505
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.010101	0.50505
RUIJS-AALFS SYNDROME; RJALS	0.010101	0.50505
BARBER-SAY SYNDROME; BBRSAY	0.010101	0.50505
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.010101	0.50505
FACIAL ECTODERMAL DYSPLASIA	0.010101	0.50505
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.010101	0.50505
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.010101	0.50505
OROFACIODIGITAL SYNDROME III	0.010101	0.50505
#613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	0.01008711	0.5043555
THROMBOCYTOPENIA, ANEMIA, AND MYELOFIBROSIS; THAMY	0.01008711	0.5043555
#139090 GRAY PLATELET SYNDROME; GPS;;BLEEDING DISORDER, PLATELET-TYPE, 4; BDPLT4;;PLATELET ALPHA-GRANULE DEFICIENCY	0.01008711	0.5043555
IMMUNODEFICIENCY 52; IMD52	0.01008711	0.5043555
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.01008711	0.5043555
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.01008711	0.5043555
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.01008711	0.5043555
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.01008711	0.5043555
#603554 OMENN SYNDROME;;RETICULOENDOTHELIOSIS, FAMILIAL, WITH EOSINOPHILIA;;SEVERE COMBINED IMMUNODEFICIENCY WITH HYPEREOSINOPHILIA	0.01008711	0.5043555
#615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8	0.01008711	0.5043555
#263300 POLYCYTHEMIA VERA;;PV;;POLYCYTHEMIA RUBRA VERA; PRV	0.01008711	0.5043555
SEA-BLUE HISTIOCYTE DISEASE	0.01008711	0.5043555
#314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT;;THROMBOCYTOPENIA, PLATELET DYSFUNCTION, HEMOLYSIS, AND IMBALANCEDGLOBIN SYNTHESIS	0.01008711	0.5043555
MIRAGE SYNDROME; MIRAGE	0.010045623	0.50228115
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.010045623	0.50228115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.009957472	0.4978736
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.009957472	0.4978736
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.009915473	0.49577364999999995
JABERI-ELAHI SYNDROME; JABELS	0.009915473	0.49577364999999995
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.009915473	0.49577364999999995
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.009915473	0.49577364999999995
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.009915473	0.49577364999999995
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.009915473	0.49577364999999995
TEMTAMY SYNDROME; TEMTYS	0.009915473	0.49577364999999995
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.009915473	0.49577364999999995
HYDROLETHALUS SYNDROME 1	0.00984337	0.4921685
HEMIFACIAL MICROSOMIA	0.00984337	0.4921685
#614120 HYDROLETHALUS SYNDROME 2; HLS2	0.00984337	0.4921685
OROFACIODIGITAL SYNDROME V; OFD5	0.00984337	0.4921685
AGNATHIA-OTOCEPHALY COMPLEX	0.00984337	0.4921685
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.00984337	0.4921685
TYSHCHENKO SYNDROME	0.009833401999999998	0.4916700999999999
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.009828759999999999	0.49143799999999993
CHROMOSOME 3q13.31 DELETION SYNDROME	0.00964642	0.48232099999999994
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00964642	0.48232099999999994
CHROMOSOME 10Q26 DELETION SYNDROME	0.009559023	0.47795115
SWEENEY-COX SYNDROME; SWCOS	0.009392132	0.4696066
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.009392132	0.4696066
MAPLE SYRUP URINE DISEASE; MSUD	0.009275721	0.46378605000000006
CYCLIC VOMITING SYNDROME	0.009275721	0.46378605000000006
MEHMO SYNDROME; MEHMO	0.009258572999999999	0.46292864999999994
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.009258572999999999	0.46292864999999994
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.009203852	0.4601926
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.009129872	0.45649360000000005
LIG4 SYNDROME	0.009129871999999999	0.45649359999999994
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00911359	0.45567949999999996
OPSISMODYSPLASIA; OPSMD	0.00911359	0.45567949999999996
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00911359	0.45567949999999996
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.009071590999999999	0.45357954999999994
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.009071590999999999	0.45357954999999994
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.009071590999999999	0.45357954999999994
CODAS SYNDROME	0.009061623000000001	0.45308115000000004
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.009061623000000001	0.45308115000000004
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.009006013	0.45030065
ARGININOSUCCINIC ACIDURIA	0.009006013	0.45030065
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.009006013	0.45030065
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.009006013	0.45030065
CHROMOSOME 19p13.13 DELETION SYNDROME	0.009006013	0.45030065
CITRULLINEMIA, CLASSIC	0.009006013	0.45030065
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.009006013	0.45030065
CRANIOSYNOSTOSIS 6; CRS6	0.008999722	0.4499861
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.008999722	0.4499861
#615401 IMMUNODEFICIENCY 8; IMD8	0.008843882	0.44219410000000003
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.008843882	0.44219410000000003
SECKEL SYNDROME 9; SCKL9	0.008843882	0.44219410000000003
LARSEN-LIKE SYNDROME	0.008840222	0.4420111
HOLOPROSENCEPHALY 7	0.008801883	0.44009415
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.008760192	0.4380096
JOUBERT SYNDROME 14	0.008760192	0.4380096
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.008620353	0.43101765000000003
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.008620353	0.43101765000000003
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.008620353	0.43101765000000003
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.008620353	0.43101765000000003
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.008620353	0.43101765000000003
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.008620352999999999	0.43101765
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.008620352999999999	0.43101765
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.008555043	0.42775215
FOLATE MALABSORPTION, HEREDITARY	0.008555043	0.42775215
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00854825	0.42741250000000003
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00848692	0.424346
#235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY	0.00848692	0.424346
#185020 CRYOHYDROCYTOSIS; CHC;;STOMATOCYTOSIS, COLD-SENSITIVE	0.00848692	0.424346
NIJMEGEN BREAKAGE SYNDROME	0.00848294	0.424147
Diamond-Blackfan anemia 1	0.00848294	0.424147
MENTAL RETARDATION, X-LINKED 102	0.008414691	0.42073455
LIVER FAILURE, INFANTILE, TRANSIENT	0.00835997	0.4179985
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00835997	0.4179985
LESCH-NYHAN SYNDROME; LNS	0.00835997	0.4179985
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00835997	0.4179985
PORPHYRIA, ACUTE HEPATIC	0.00835997	0.4179985
ACID PHOSPHATASE DEFICIENCY	0.00835997	0.4179985
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00835997	0.4179985
FANCONI ANEMIA	0.00828599	0.4142995
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.00828599	0.4142995
WT LIMB-BLOOD SYNDROME	0.00828599	0.4142995
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.00828599	0.4142995
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.008278513000000001	0.41392565000000003
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.008278513	0.41392565
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.008162131	0.40810654999999996
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.008162131	0.40810654999999996
PAPILLOMA OF CHOROID PLEXUS	0.008162131	0.40810654999999996
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.008162131	0.40810654999999996
CHIARI MALFORMATION TYPE II	0.00815584	0.407792
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00815584	0.407792
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.008145871999999998	0.4072935999999999
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.008144983	0.40724915
CILIARY DYSKINESIA, PRIMARY, 35; CILD35	0.008	0.4
CD8 DEFICIENCY, FAMILIAL	0.008	0.4
IMMUNODEFICIENCY 58; IMD58	0.008	0.4
#610913 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2;;INTERSTITIAL LUNG DISEASE DUE TO SURFACTANT PROTEIN C DEFICIENCY;;DESQUAMATIVE INTERSTITIAL PNEUMONITIS DUE TO SURFACTANT PROTEIN CDEFICIENCY;;PULMONARY ALVEOLAR PROTEINOSIS, CONGENITAL, 2	0.008	0.4
IMMUNODEFICIENCY 57; IMD57	0.008	0.4
#610852 CILIARY DYSKINESIA, PRIMARY, 6; CILD6	0.008	0.4
#613807 CILIARY DYSKINESIA, PRIMARY, 14; CILD14;;CILIARY DYSKINESIA, PRIMARY, 14, WITH OR WITHOUT SITUS INVERSUS	0.008	0.4
ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL DOMINANT	0.008	0.4
LICHTENSTEIN SYNDROME	0.008	0.4
CILIARY DYSKINESIA, PRIMARY, 29; CILD29	0.008	0.4
CILIARY DYSKINESIA, PRIMARY, 30; CILD30	0.008	0.4
COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	0.008	0.4
GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF	0.008	0.4
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.008	0.4
#615615 IMMUNODEFICIENCY 18; IMD18;;CD3-EPSILON DEFICIENCYIMMUNODEFICIENCY 18, SEVERE COMBINED IMMUNODEFICIENCY VARIANT, INCLUDED;;IMMUNODEFICIENCY 18, SCID VARIANT, INCLUDED	0.008	0.4
#615214 AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE; AGM7;;AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO PIK3R1 DEFECT	0.008	0.4
CILIARY DYSKINESIA, PRIMARY, 32; CILD32	0.008	0.4
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.008	0.4
SPINAL MUSCULAR ATROPHY, TYPE II	0.008	0.4
HYPER-IgE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.008	0.4
RETINITIS PIGMENTOSA 6	0.008	0.4
ODONTOCHONDRODYSPLASIA; ODCD	0.008	0.4
#615139 FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS	0.008	0.4
#608644 CILIARY DYSKINESIA, PRIMARY, 3; CILD3;;CILIARY DYSKINESIA, PRIMARY, 3, WITH OR WITHOUT SITUS INVERSUS	0.008	0.4
IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1	0.008	0.4
#253300 SPINAL MUSCULAR ATROPHY, TYPE I; SMA1;;SMA I;;SMA, INFANTILE ACUTE FORM;;MUSCULAR ATROPHY, INFANTILE;;WERDNIG-HOFFMANN DISEASE	0.008	0.4
CILIARY DYSKINESIA, PRIMARY, 39; CILD39	0.008	0.4
OSTEODYSPLASTY, PRECOCIOUS, OF DANKS, MAYNE, AND KOZLOWSKI	0.008	0.4
THORACIC DYSOSTOSIS, ISOLATED	0.008	0.4
IMMUNODEFICIENCY, COMMON VARIABLE, 11; CVID11	0.008	0.4
#611521 IMMUNODEFICIENCY 35; IMD35;;TYROSINE KINASE 2 DEFICIENCY;;TYK2 DEFICIENCY;;HYPER-IgE SYNDROME WITH ATYPICAL MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE;;HIES WITH ATYPICAL MYCOBACTERIOSIS, AUTOSOMAL RECESSIVE	0.008	0.4
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.008	0.4
#614699 IMMUNODEFICIENCY, COMMON VARIABLE, 7; CVID7	0.008	0.4
PULMONARY ALVEOLAR PROTEINOSIS WITH HYPOGAMMAGLOBULINEMIA; PAPHG	0.008	0.4
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.008	0.4
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.008	0.4
#613808 CILIARY DYSKINESIA, PRIMARY, 15; CILD15;;CILIARY DYSKINESIA, PRIMARY, 15, WITH OR WITHOUT SITUS INVERSUS	0.008	0.4
NEUTROPENIA, SEVERE CONGENITAL, 6, AUTOSOMAL RECESSIVE; SCN6	0.008	0.4
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.008	0.4
IMMUNODEFICIENCY 43	0.008	0.4
IMMUNODEFICIENCY 22; IMD22	0.008	0.4
#613495 IMMUNODEFICIENCY, COMMON VARIABLE, 5; CVID5;;ANTIBODY DEFICIENCY DUE TO CD20 DEFECT	0.008	0.4
#255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MINICORE MYOPATHY;;MULTICORE MYOPATHY;;MULTIMINICORE MYOPATHY MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA;;MULTIMINICORE DISEASE WITH EXTERNAL OPHTHALMOPLEGIA	0.008	0.4
#615617 IMMUNODEFICIENCY 19; IMD19;;CD3-DELTA DEFICIENCY;;SEVERE COMBINED IMMUNODEFICIENCY, T CELL-NEGATIVE, B CELL-POSITIVE,NK CELL-POSITIVE;;SCID, T CELL-NEGATIVE, B CELL-POSITIVE, NK CELL-POSITIVE	0.008	0.4
CILIARY DYSKINESIA, PRIMARY, 17; CILD17	0.008	0.4
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.008	0.4
#612650 CILIARY DYSKINESIA, PRIMARY, 12; CILD12	0.008	0.4
CILIARY DYSKINESIA, PRIMARY, 7; CILD7	0.008	0.4
IMMUNODEFICIENCY 53; IMD53	0.008	0.4
#613953 CANDIDIASIS, FAMILIAL, 5; CANDF5;;CANDIDIASIS, FAMILIAL CHRONIC MUCOCUTANEOUS, AUTOSOMAL RECESSIVE	0.008	0.4
PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED	0.008	0.4
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.008	0.4
#615206 CARD11 IMMUNODEFICIENCY	0.008	0.4
ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS, AND HYPER-IgE; EPKHE	0.008	0.4
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.008	0.4
#606763 CILIARY DYSKINESIA, PRIMARY, 2; CILD2;;CILIARY DYSKINESIA, PRIMARY, 2, WITH OR WITHOUT SITUS INVERSUS	0.008	0.4
BARAITSER-WINTER SYNDROME 2; BRWS2	0.007958001	0.39790004999999995
LISSENCEPHALY, X-LINKED, 1; LISX1	0.007958001	0.39790004999999995
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.007958001	0.39790004999999995
ARTERIAL TORTUOSITY SYNDROME	0.00791631	0.3958155
SEPTOOPTIC DYSPLASIA	0.007886132	0.3943066
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.007886132	0.3943066
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.007886132	0.3943066
OCULOSKELETODENTAL SYNDROME; OCSKD	0.007853342	0.39266709999999994
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.007798501	0.38992505
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.007718471	0.38592355
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.007718471	0.38592355
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.007718471	0.38592355
SNEDDON SYNDROME	0.007718471	0.38592355
KEUTEL SYNDROME; KTLS	0.007718471	0.38592355
NEUROFIBROMATOSIS, TYPE I	0.007718471	0.38592355
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.007718471	0.38592355
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.007704602	0.38523009999999996
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.007704602	0.38523009999999996
JOUBERT SYNDROME 25	0.007704602	0.38523009999999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.007704602	0.38523009999999996
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.007704602	0.38523009999999996
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.007646602	0.3823301
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.007646602	0.3823301
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.007646602	0.3823301
BARDET-BIEDL SYNDROME 1; BBS1	0.007646602	0.3823301
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.007639292	0.3819646
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.007506763	0.37533815
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.007506763	0.37533815
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.007506763	0.37533815
PHACE ASSOCIATION	0.007506763	0.37533815
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.007506763	0.37533815
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00749894	0.374947
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.007434631000000001	0.37173155
PALLISTER-KILLIAN SYNDROME	0.007434631000000001	0.37173155
AU-KLINE SYNDROME; AUKS	0.007362762	0.3681381
Mental retardation, autosomal dominant 21	0.007362762	0.3681381
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.007362762	0.3681381
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0073019899999999995	0.36509949999999997
INFANTILE SIALIC ACID STORAGE DISEASE	0.007278513	0.36392565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.007278513	0.36392565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.007278513	0.36392565
KAGAMI-OGATA SYNDROME	0.007278513	0.36392565
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00724638	0.362319
VISCERAL MYOPATHY; VSCM	0.00724638	0.362319
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00724638	0.362319
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00724638	0.362319
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00724638	0.362319
GALACTOSEMIA	0.00724638	0.362319
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00724638	0.362319
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00724638	0.362319
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.00724638	0.362319
CONGENITAL SHORT BOWEL SYNDROME	0.00724638	0.362319
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00724638	0.362319
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00724638	0.362319
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00724638	0.362319
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00724638	0.362319
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.00724638	0.362319
EPISODIC ATAXIA, TYPE 3	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00724638	0.362319
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00724638	0.362319
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00724638	0.362319
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.00724638	0.362319
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00724638	0.362319
PORPHYRIA VARIEGATA	0.00724638	0.362319
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00724638	0.362319
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00724638	0.362319
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00724638	0.362319
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00724638	0.362319
ANGIOEDEMA, HEREDITARY, TYPE III	0.00724638	0.362319
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00724638	0.362319
ALPHA-METHYLACETOACETIC ACIDURIA	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00724638	0.362319
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00724638	0.362319
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00724638	0.362319
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00724638	0.362319
CHYLOMICRON RETENTION DISEASE	0.00724638	0.362319
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00724638	0.362319
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00724638	0.362319
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00724638	0.362319
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00724638	0.362319
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.00724638	0.362319
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00724638	0.362319
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00724638	0.362319
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00724638	0.362319
VALINEMIA	0.00724638	0.362319
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.007164923	0.35824615
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.007164923	0.35824615
CATEL-MANZKE SYNDROME; CATMANS	0.007164923	0.35824615
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.0071041509999999995	0.35520755
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.0071041509999999995	0.35520755
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.0071041509999999995	0.35520755
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00704225	0.3521125
MASA SYNDROME	0.00704225	0.3521125
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00704225	0.3521125
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00704225	0.3521125
FETAL AKINESIA SYNDROME, X-LINKED	0.00704225	0.3521125
SCHIZENCEPHALY	0.00704225	0.3521125
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00704225	0.3521125
OROFACIODIGITAL SYNDROME XV; OFD15	0.00704225	0.3521125
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00704225	0.3521125
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00704225	0.3521125
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00704225	0.3521125
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00704225	0.3521125
MIRROR MOVEMENTS 1; MRMV1	0.00704225	0.3521125
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.007032281999999999	0.35161409999999993
SALLA DISEASE	0.006954853	0.34774265000000004
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.006954853	0.34774265000000004
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.006954853	0.34774265000000004
%608572 BURN-MCKEOWN SYNDROME	0.00688275	0.3441375
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.00688275	0.3441375
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00686072	0.343036
CEREBELLAR HYPOPLASIA	0.00686072	0.343036
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00680272	0.340136
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00680272	0.340136
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 3	0.00680272	0.340136
#112410 HYPERTENSION AND BRACHYDACTYLY SYNDROME; HTNB;;BRACHYDACTYLY WITH HYPERTENSION;;BRACHYDACTYLY, TYPE E, WITH SHORT STATURE AND HYPERTENSION;;BILGINTURAN SYNDROME	0.00680272	0.340136
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.00680272	0.340136
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00680272	0.340136
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00680272	0.340136
#614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B	0.00680272	0.340136
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00680272	0.340136
#615378 ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14	0.00680272	0.340136
#613677 HYPERALDOSTERONISM, FAMILIAL, TYPE III;;FH III	0.00680272	0.340136
ALAGILLE SYNDROME 2	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00680272	0.340136
#613877 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4;;LIPODYSTROPHY, FAMILIAL PARTIAL, ASSOCIATED WITH PLIN1 MUTATIONS	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00680272	0.340136
ROWLEY-ROSENBERG SYNDROME	0.00680272	0.340136
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00680272	0.340136
LONG QT SYNDROME 13; LQT13	0.00680272	0.340136
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00680272	0.340136
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00680272	0.340136
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00680272	0.340136
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE IA	0.00680272	0.340136
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00680272	0.340136
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00680272	0.340136
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 2	0.00680272	0.340136
POLYCYSTIC KIDNEYS	0.00680272	0.340136
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.00680272	0.340136
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00680272	0.340136
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00680272	0.340136
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00680272	0.340136
HUNTER-MACDONALD SYNDROME	0.00680272	0.340136
LIDDLE SYNDROME 1; LIDLS1	0.00680272	0.340136
#614473 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2	0.00680272	0.340136
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.00680272	0.340136
LIDDLE SYNDROME 3; LIDLS3	0.00680272	0.340136
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00680272	0.340136
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00680272	0.340136
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00680272	0.340136
#218030 APPARENT MINERALOCORTICOID EXCESS; AME;;AME1;;CORTISOL 11-BETA-KETOREDUCTASE DEFICIENCY	0.00680272	0.340136
SECKEL SYNDROME 10; SCKL10	0.00680272	0.340136
#601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.00680272	0.340136
#194080 DENYS-DRASH SYNDROME; DDS;;DRASH SYNDROME;;WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM;;NEPHROPATHY, WILMS TUMOR, AND GENITAL ANOMALIES	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.00680272	0.340136
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00680272	0.340136
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00680272	0.340136
#614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D;;FAMILIAL HYPERKALEMIC HYPERTENSION; FHHT	0.00680272	0.340136
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00680272	0.340136
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00680272	0.340136
#605115 HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATIONIN PREGNANCY	0.00680272	0.340136
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00680272	0.340136
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00680272	0.340136
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00680272	0.340136
GLYCOGEN STORAGE DISEASE IB	0.00680272	0.340136
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.00680272	0.340136
#602088 NEPHRONOPHTHISIS 2; NPHP2;;NPH2	0.00680272	0.340136
NEPHRONOPHTHISIS 1	0.00680272	0.340136
IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00680272	0.340136
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.00680272	0.340136
XFE PROGEROID SYNDROME; XFEPS	0.00680272	0.340136
Paragangliomas 6	0.00680272	0.340136
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00680272	0.340136
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00680272	0.340136
%613944 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00680272	0.340136
#178600 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1;;PHT;;PULMONARY ARTERIAL HYPERTENSION; PAHPULMONARY HYPERTENSION, PRIMARY, DEXFENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, FENFLURAMINE-ASSOCIATED, INCLUDED;;PULMONARY HYPERTENSION, PRIMARY, 1, WITH HEREDITARY HEMORRHAGIC TELANGIECTASIA,INCLUDED;;PPH1 WITH HHT, INCLUDED	0.00680272	0.340136
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00680272	0.340136
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00680272	0.340136
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00680272	0.340136
#607832 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3;;GLOMERULOSCLEROSIS, FOCAL SEGMENTAL, 3, SUSCEPTIBILITY TO	0.00680272	0.340136
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00680272	0.340136
LIDDLE SYNDROME 2; LIDLS2	0.00680272	0.340136
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00680272	0.340136
SENGERS SYNDROME	0.00679541	0.3397705
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00679541	0.3397705
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.0066858	0.33429000000000003
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0066858	0.33429000000000003
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.0066858	0.33429000000000003
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.0066858	0.33429000000000003
TESTICULAR GERM CELL TUMOR; TGCT	0.0066858	0.33429000000000003
ICHTHYOSIS, X-LINKED	0.0066858	0.33429000000000003
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.006662881	0.33314404999999997
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.006597571	0.32987855
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.006597571	0.32987855
THYROCEREBRORETINAL SYNDROME	0.006597571	0.32987855
#610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY	0.006597571	0.32987855
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.006597571	0.32987855
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.006597571	0.32987855
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.006591011999999999	0.32955059999999997
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.006591011999999999	0.32955059999999997
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.006591011999999999	0.32955059999999997
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.006591011999999999	0.32955059999999997
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.006591011999999999	0.32955059999999997
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.006591011999999999	0.32955059999999997
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.006591011999999999	0.32955059999999997
MECKEL SYNDROME 13; MKS13	0.006591011999999999	0.32955059999999997
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.006591011999999999	0.32955059999999997
CEREBELLOFACIODENTAL SYNDROME	0.006591011999999999	0.32955059999999997
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.0065257019999999995	0.3262851
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0065257019999999995	0.3262851
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.0065257019999999995	0.3262851
FORSYTHE-WAKELING SYNDROME; FWS	0.0065257019999999995	0.3262851
TEMPLE SYNDROME	0.0065188799999999995	0.32594399999999996
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.006457453	0.32287265
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.006457453	0.32287265
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.006457453	0.32287265
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.006457453	0.32287265
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.006457453	0.32287265
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.006457453	0.32287265
AL KAISSI SYNDROME; ALKAS	0.006457453	0.32287265
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.006457453	0.32287265
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.006457453	0.32287265
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.006457453	0.32287265
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.006457453	0.32287265
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.006457453	0.32287265
NEURAMINIDASE DEFICIENCY	0.006434631	0.32173155
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00638535	0.3192675
MECKEL SYNDROME, TYPE 4; MKS4	0.00638535	0.3192675
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.006362762	0.3181381
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.006362762	0.3181381
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.0063210409999999995	0.31605205
BRANCHIOOCULOFACIAL SYNDROME	0.0063210409999999995	0.31605205
CHROMOSOME 15q25 DELETION SYNDROME	0.006249172	0.3124586
CULLER-JONES SYNDROME; CJS	0.006249172	0.3124586
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.006249171999999999	0.3124586
Aarskog-Scott syndrome	0.006249171999999999	0.3124586
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.006249171999999999	0.3124586
MEIER-GORLIN SYNDROME 7	0.006249171999999999	0.3124586
3MC SYNDROME 2	0.006249171999999999	0.3124586
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.006164923	0.30824615
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.006110971000000001	0.30554855000000003
XYLOSIDASE DEFICIENCY	0.006110971000000001	0.30554855000000003
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.006110971000000001	0.30554855000000003
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.005841263	0.29206315
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.005841263	0.29206315
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00574713	0.28735649999999996
Trichothiodystrophy 5, nonphotosensitive	0.00574713	0.28735649999999996
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00574713	0.28735649999999996
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00574713	0.28735649999999996
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.00574713	0.28735649999999996
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS, 1; HGPPS1	0.00574713	0.28735649999999996
GILLESPIE SYNDROME; GLSP	0.00574713	0.28735649999999996
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.00574713	0.28735649999999996
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00574713	0.28735649999999996
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.00574713	0.28735649999999996
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.00574713	0.28735649999999996
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00574713	0.28735649999999996
PLATELET SIGNAL PROCESSING DEFECT	0.00568182	0.284091
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00568182	0.284091
IMMUNODEFICIENCY, COMMON VARIABLE, 12; CVID12	0.00568182	0.284091
#608404 PLATELET GLYCOPROTEIN IV DEFICIENCY;;BLEEDING DISORDER, PLATELET-TYPE, 10; BDPLT10;;CD36 DEFICIENCY	0.00568182	0.284091
THROMBOCYTOPENIA WITH ELEVATED SERUM IGA AND RENAL DISEASE	0.00568182	0.284091
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP;;IMMUNE THROMBOCYTOPENIC PURPURA; ITP;;IDIOPATHIC THROMBOCYTOPENIC PURPURA	0.00568182	0.284091
THROMBOCYTOPENIA, CYCLIC	0.00568182	0.284091
#615715 BONE MARROW FAILURE SYNDROME 2; BMFS2	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.00568182	0.284091
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00568182	0.284091
STORMORKEN SYNDROME; STRMK	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00568182	0.284091
THROMBOCYTOPENIA 5; THC5	0.00568182	0.284091
Bernard-Soulier syndrome	0.00568182	0.284091
167850 PANCYTOPENIA AND OCCLUSIVE VASCULAR DISEASE	0.00568182	0.284091
NEPHROTIC SYNDROME, TYPE 7; NPHS7	0.00568182	0.284091
EOSINOPHILIA, FAMILIAL	0.00568182	0.284091
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00568182	0.284091
#613987 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00568182	0.284091
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00568182	0.284091
#188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT;;CHROMOSOME 11q23 DELETION SYNDROME	0.00568182	0.284091
SEBASTIAN SYNDROME	0.00568182	0.284091
#612004 THROMBOCYTOPENIA 4; THC4;;THROMBOCYTOPENIA, AUTOSOMAL DOMINANT, 4	0.00568182	0.284091
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00568182	0.284091
BEEMER LETHAL MALFORMATION SYNDROME	0.00568182	0.284091
THROMBOCYTOPENIA 3	0.00568182	0.284091
HERMANSKY-PUDLAK SYNDROME 9	0.00568182	0.284091
DK PHOCOMELIA SYNDROME	0.00568182	0.284091
PLATELET DISORDER, UNDEFINED	0.00568182	0.284091
#231095 GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD;;GHOSAL SYNDROME	0.00568182	0.284091
IVIC SYNDROME	0.00568182	0.284091
%614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9;;GLYCOPROTEIN Ia DEFICIENCY;;GP Ia DEFICIENCY;;COLLAGEN PLATELET RECEPTOR DEFICIENCY	0.00568182	0.284091
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00568182	0.284091
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.00568182	0.284091
#300835 ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES;XLANP	0.00568182	0.284091
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.00568182	0.284091
FECHTNER SYNDROME	0.00568182	0.284091
PLATELET ABNORMALITIES WITH EOSINOPHILIA AND IMMUNE-MEDIATED INFLAMMATORY DISEASE; PLTEID	0.00568182	0.284091
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00568182	0.284091
THROMBOCYTOPENIA 6	0.00568182	0.284091
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00568182	0.284091
#259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2;;OSTEOPETROSIS, OSTEOCLAST-POOR;;OSTEOPETROSIS, MILD AUTOSOMAL RECESSIVE FORM	0.00568182	0.284091
#614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8	0.00568182	0.284091
THROMBOCYTOPENIA 2	0.00568182	0.284091
GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA	0.00568182	0.284091
#601709 QUEBEC PLATELET DISORDER; QPD;;BLEEDING DISORDER, PLATELET-TYPE, 5; BDPLT5;;FACTOR V QUEBEC	0.00568182	0.284091
FANCONI ANEMIA, COMPLEMENTATION GROUP T; FANCT	0.00568182	0.284091
MONOSOMY 7 OF BONE MARROW	0.00568182	0.284091
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.005674343	0.28371715000000003
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.005674343	0.28371715000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.005674343	0.28371715000000003
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.005674343	0.28371715000000003
#300867 KABUKI SYNDROME 2; KABUK2	0.005674343	0.28371715000000003
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.005674343	0.28371715000000003
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.005674343	0.28371715000000003
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.005613571	0.28067855
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.005613571	0.28067855
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.0056135709999999995	0.28067854999999997
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.0056135709999999995	0.28067854999999997
XIA-GIBBS SYNDROME	0.005541702	0.2770851
JOUBERT SYNDROME 21	0.005541702	0.2770851
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.005541702	0.2770851
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.005541702	0.2770851
JOUBERT SYNDROME 31; JBTS31	0.005541702	0.2770851
GLYCOGEN STORAGE DISEASE IXC	0.00551888	0.275944
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00551888	0.275944
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00551888	0.275944
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0054773930000000005	0.27386965
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0054773930000000005	0.27386965
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0054773930000000005	0.27386965
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0054773930000000005	0.27386965
CHROMOSOME 16p13.2 DELETION SYNDROME	0.0054773930000000005	0.27386965
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.0054773930000000005	0.27386965
WEAVER SYNDROME	0.0054773930000000005	0.27386965
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0054773930000000005	0.27386965
MEND SYNDROME; MEND	0.0054773930000000005	0.27386965
Glycosylphosphatidylinositol biosynthesis defect 18	0.0054773930000000005	0.27386965
C SYNDROME	0.0054773930000000005	0.27386965
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00540529	0.2702645
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00540529	0.2702645
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00540529	0.2702645
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00540529	0.2702645
POPLITEAL PTERYGIUM SYNDROME	0.00540529	0.2702645
#150250 LARSEN SYNDROME; LRS	0.00540529	0.2702645
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00540529	0.2702645
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.00540529	0.2702645
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00540529	0.2702645
FACIOCARDIORENAL SYNDROME	0.00540529	0.2702645
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.00540529	0.2702645
CHARGE SYNDROME	0.00540529	0.2702645
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.00540529	0.2702645
ROBERTS SYNDROME; RBS	0.00540529	0.2702645
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00540529	0.2702645
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00540529	0.2702645
ATELOSTEOGENESIS, TYPE I; AO1	0.00540529	0.2702645
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.00540529	0.2702645
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.00540529	0.2702645
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00540529	0.2702645
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00540529	0.2702645
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005343863	0.26719315
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.005343863	0.26719315
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.005343863	0.26719315
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.005343863	0.26719315
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.005343863	0.26719315
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.005343863	0.26719315
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.005343863	0.26719315
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.005343863	0.26719315
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.005343863	0.26719315
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.005343863	0.26719315
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.005343863	0.26719315
MENTAL RETARDATION, X-LINKED 104; MRX104	0.005343863	0.26719315
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.005321041	0.26605205000000004
IMMUNODEFICIENCY 47	0.005321041	0.26605205000000004
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.005321041	0.26605205000000004
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.005321041	0.26605205000000004
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.005321041	0.26605205000000004
GAUCHER DISEASE, TYPE IIIC	0.005321041	0.26605205000000004
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.005249172	0.2624586
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.005249172	0.2624586
LYMPHEDEMA, HEREDITARY, III	0.005249172	0.2624586
MACROCEPHALY/AUTISM SYNDROME	0.005249172	0.2624586
ETHANOLAMINOSIS	0.00519522	0.259761
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00519522	0.259761
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00519522	0.259761
EHLERS-DANLOS SYNDROME, TYPE VI	0.00519522	0.259761
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00519522	0.259761
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00519522	0.259761
ICHTHYOSIS AND MALE HYPOGONADISM	0.004997381	0.24986905
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004997381	0.24986905
HYPERLEUCINE-ISOLEUCINEMIA	0.004997381	0.24986905
EPILEPSY-TELANGIECTASIA	0.004997381	0.24986905
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004925512	0.24627559999999998
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.004830461	0.24152305000000002
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.004830461	0.24152305000000002
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.004758592	0.2379296
DESBUQUOIS DYSPLASIA 2; DBQD2	0.004758592	0.2379296
RITSCHER-SCHINZEL SYNDROME 1	0.004758592	0.2379296
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00469782	0.23489100000000002
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00469782	0.23489100000000002
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.00469782	0.23489100000000002
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00469782	0.23489100000000002
OHDO SYNDROME	0.004633511	0.23167555
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.004633511	0.23167555
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.004633511	0.23167555
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.004561641999999999	0.22808209999999998
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.004561641999999999	0.22808209999999998
NOONAN SYNDROME 6; NS6	0.004561641999999999	0.22808209999999998
TONNE-KALSCHEUER SYNDROME; TOKAS	0.004561641999999999	0.22808209999999998
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.004561641999999999	0.22808209999999998
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.004561641999999999	0.22808209999999998
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.004561641999999999	0.22808209999999998
DIGEORGE SYNDROME; DGS	0.004560753	0.22803764999999998
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.004560753	0.22803764999999998
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.004499981	0.22499905
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.004499981	0.22499905
#612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME	0.004499981	0.22499905
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.004499981	0.22499905
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.004499981	0.22499905
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.004499981	0.22499905
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.004499981	0.22499905
#609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1;;HEPATOENCEPHALOPATHY, EARLY FATAL PROGRESSIVE	0.004499981	0.22499905
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004499981	0.22499905
RETT SYNDROME, CONGENITAL VARIANT	0.004499981	0.22499905
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.004428112	0.22140559999999998
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.004428112	0.22140559999999998
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.004428112	0.22140559999999998
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.004428112	0.22140559999999998
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.004428112	0.22140559999999998
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.004428112	0.22140559999999998
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.004428112	0.22140559999999998
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.004428112	0.22140559999999998
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.004428112	0.22140559999999998
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.004428112	0.22140559999999998
#613673 ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE IV; CDAN4	0.00440529	0.2202645
HEMOCHROMATOSIS, TYPE 2B	0.00440529	0.2202645
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00440529	0.2202645
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.00440529	0.2202645
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00440529	0.2202645
#612690 SPHEROCYTOSIS, TYPE 5; SPH5;;SPHEROCYTOSIS, HEREDITARY, 5; HS5	0.00440529	0.2202645
PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL	0.00440529	0.2202645
OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS; OMPP	0.00440529	0.2202645
#612653 SPHEROCYTOSIS, TYPE 4; SPH4;;SPHEROCYTOSIS, HEREDITARY, 4; HS4	0.00440529	0.2202645
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00440529	0.2202645
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 1	0.00440529	0.2202645
B-CELL EXPANSION WITH NFKB AND T-CELL ANERGY; BENTA	0.00440529	0.2202645
#614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CDGX	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II; CDG2	0.00440529	0.2202645
CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEINLIPASE	0.00440529	0.2202645
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00440529	0.2202645
PYRUVATE KINASE DEFICIENCY OF RED CELLS	0.00440529	0.2202645
HEMOGLOBIN--BETA LOCUS	0.00440529	0.2202645
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00440529	0.2202645
FELTY SYNDROME	0.00440529	0.2202645
OSTEOPETROSIS, AUTOSOMAL DOMINANT 3; OPTA3	0.00440529	0.2202645
REYNOLDS SYNDROME	0.00440529	0.2202645
ANEMIA, SIDEROBLASTIC, 3, PYRIDOXINE-REFRACTORY; SIDBA3	0.00440529	0.2202645
HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB	0.00440529	0.2202645
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00440529	0.2202645
THROMBOCYTOSIS, FAMILIAL X-LINKED	0.00440529	0.2202645
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.00440529	0.2202645
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRINMETABOLISM	0.00440529	0.2202645
SPLENOMEGALY, CYTOPENIA, AND VISION LOSS	0.00440529	0.2202645
IMMUNODEFICIENCY 16	0.00440529	0.2202645
#613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASEDEFICIENCY	0.00440529	0.2202645
#228000 FARBER LIPOGRANULOMATOSIS;;FARBER DISEASE;;CERAMIDASE DEFICIENCY;;ACID CERAMIDASE DEFICIENCY;;AC DEFICIENCY;;N-LAURYLSPHINGOSINE DEACYLASE DEFICIENCY	0.00440529	0.2202645
#185000 OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHS;;POTASSIUM-SODIUM DISORDER OF ERYTHROCYTE	0.00440529	0.2202645
Lipodystrophy, congenital generalized, type 2	0.00440529	0.2202645
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00440529	0.2202645
SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2	0.00440529	0.2202645
GLYCOPROTEIN STORAGE DISEASE	0.00440529	0.2202645
#613978 HEMOGLOBIN H DISEASE; HBH;;ALPHA-THALASSEMIA, HEMOGLOBIN H TYPE;;HEMOGLOBIN H DISEASE, DELETIONALHEMOGLOBIN H DISEASE, NONDELETIONAL, INCLUDED	0.00440529	0.2202645
IMMUNODEFICIENCY 60; IMD60	0.00440529	0.2202645
#607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1;;ANTIBODY DEFICIENCY DUE TO ICOS DEFECTIMMUNODEFICIENCY, COMMON VARIABLE, INCLUDED; CVID, INCLUDED	0.00440529	0.2202645
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3	0.00440529	0.2202645
SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA ANDREDUCED CIRCULATING T-HELPER CELLS	0.00440529	0.2202645
TYROSINEMIA, TYPE I; TYRSN1	0.00440529	0.2202645
#615513 IMMUNODEFICIENCY 14; IMD14;;ACTIVATED PI3K-DELTA SYNDROME; APDS;;P110-DELTA-ACTIVATING MUTATION CAUSING SENESCENT T CELLS, LYMPHADENOPATHY,AND IMMUNODEFICIENCY; PASLI	0.00440529	0.2202645
HYPERLIPOPROTEINEMIA, TYPE ID	0.00440529	0.2202645
NEPHRONOPHTHISIS 19; NPHP19	0.00440529	0.2202645
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.00440529	0.2202645
#616278 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 5; CBAS5	0.00440529	0.2202645
RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS	0.00440529	0.2202645
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2	0.00440529	0.2202645
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE	0.00440529	0.2202645
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.00440529	0.2202645
PROTEUS SYNDROME	0.00440529	0.2202645
HEMOCHROMATOSIS, TYPE 1	0.00440529	0.2202645
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.00440529	0.2202645
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.00440529	0.2202645
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2	0.00440529	0.2202645
#224120 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;;CDA Ia;;ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	0.00440529	0.2202645
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.00440529	0.2202645
ANEMIA, DYSERYTHROPOIETIC CONGENITAL, TYPE II	0.00440529	0.2202645
SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1	0.00440529	0.2202645
APOLIPOPROTEIN C-II DEFICIENCY	0.00440529	0.2202645
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00440529	0.2202645
ELLIPTOCYTOSIS 1; EL1	0.00440529	0.2202645
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00440529	0.2202645
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.00440529	0.2202645
GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE I; CDG1	0.00440529	0.2202645
SPHEROCYTOSIS, TYPE 1; SPH1	0.00440529	0.2202645
DEHYDRATED HEREDITARY STOMATOCYTOSIS 2; DHS2	0.00440529	0.2202645
#604173 POIKILODERMA WITH NEUTROPENIA; PN;;POIKILODERMA WITH NEUTROPENIA, CLERICUZIO-TYPE	0.00440529	0.2202645
#269840 SELECTIVE T-CELL DEFECT; STCD	0.00440529	0.2202645
Lipodystrophy, congenital generalized, type 1	0.00440529	0.2202645
SPHEROCYTOSIS, TYPE 2	0.00440529	0.2202645
HEMOCHROMATOSIS, TYPE 2A	0.00440529	0.2202645
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.004363802999999999	0.21819014999999997
PALLISTER-HALL SYNDROME	0.004363802999999999	0.21819014999999997
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.004363802999999999	0.21819014999999997
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.004363802999999999	0.21819014999999997
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.004363802999999999	0.21819014999999997
CHROMOSOME 1p35 DELETION SYNDROME	0.004363802999999999	0.21819014999999997
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.004363802999999999	0.21819014999999997
KBG SYNDROME	0.004363802999999999	0.21819014999999997
Pierpont syndrome	0.004363802999999999	0.21819014999999997
SCHAAF-YANG SYNDROME; SHFYNG	0.004363802999999999	0.21819014999999997
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.004363802999999999	0.21819014999999997
GLUTATHIONURIA	0.00408163	0.2040815
PERRY SYNDROME	0.00408163	0.2040815
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00408163	0.2040815
PARAOXONASE 1	0.00408163	0.2040815
SCHIZOPHRENIA 4	0.00408163	0.2040815
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00408163	0.2040815
LYMPHOKINE DEFICIENCY	0.00408163	0.2040815
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00408163	0.2040815
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00408163	0.2040815
LACTOSE INTOLERANCE, ADULT TYPE	0.00408163	0.2040815
CALVARIAL HYPEROSTOSIS	0.00408163	0.2040815
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00408163	0.2040815
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00408163	0.2040815
NORMOKALEMIC PERIODIC PARALYSIS	0.00408163	0.2040815
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.00408163	0.2040815
TRISOMY 18-LIKE SYNDROME	0.00408163	0.2040815
HEINZ BODY ANEMIAS	0.00408163	0.2040815
ACETYLATION, SLOW	0.00408163	0.2040815
DELETED IN AZOOSPERMIA	0.00408163	0.2040815
OCULORENOCEREBELLAR SYNDROME	0.00408163	0.2040815
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00408163	0.2040815
WHITE SPONGE NEVUS OF CANNON	0.00408163	0.2040815
APOLIPOPROTEIN(A)	0.00408163	0.2040815
PYGMY	0.00408163	0.2040815
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00408163	0.2040815
FETAL IODINE DEFICIENCY DISORDER	0.00408163	0.2040815
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00408163	0.2040815
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00408163	0.2040815
LIPASE DEFICIENCY, COMBINED	0.00408163	0.2040815
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00408163	0.2040815
ONCOCYTOMA	0.00408163	0.2040815
#270960 SPERMATOGENIC FAILURE 4; SPGF4;;AZOOSPERMIA DUE TO PERTURBATIONS OF MEIOSIS;;AZOOSPERMIA WITH MATURATION ARREST;;SPERMATOGENESIS ARRESTPREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 4; RPRGL4	0.00408163	0.2040815
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00408163	0.2040815
#143860 HYPERCHLORHIDROSIS, ISOLATED	0.00408163	0.2040815
HYPERPROGLUCAGONEMIA	0.00408163	0.2040815
MYOPATHY, SPHEROID BODY	0.00408163	0.2040815
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00408163	0.2040815
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00408163	0.2040815
ZINC, ELEVATED PLASMA	0.00408163	0.2040815
OSTEOGENIC SARCOMA	0.00408163	0.2040815
GLUTATHIONE REDUCTASE	0.00408163	0.2040815
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00408163	0.2040815
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00408163	0.2040815
OSTEOGENESIS IMPERFECTA, TYPE V	0.00408163	0.2040815
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00408163	0.2040815
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00408163	0.2040815
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00408163	0.2040815
CARDIAC LIPIDOSIS, FAMILIAL	0.00408163	0.2040815
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00408163	0.2040815
T-SUBSTANCE ANOMALY	0.00408163	0.2040815
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00408163	0.2040815
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00408163	0.2040815
LARON SYNDROME	0.00408163	0.2040815
#225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5	0.00408163	0.2040815
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00408163	0.2040815
HYPOASCORBEMIA	0.00408163	0.2040815
CITRULLINE TRANSPORT DEFECT	0.00408163	0.2040815
GLOMUVENOUS MALFORMATIONS	0.00408163	0.2040815
PACMAN DYSPLASIA	0.00408163	0.2040815
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00408163	0.2040815
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00408163	0.2040815
PENDRED SYNDROME	0.00408163	0.2040815
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00408163	0.2040815
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00408163	0.2040815
SERTOLI CELL-ONLY SYNDROME	0.00408163	0.2040815
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00408163	0.2040815
SPERMATOGENIC FAILURE 1; SPGF1	0.00408163	0.2040815
KERATOSIS, FAMILIAL ACTINIC	0.00408163	0.2040815
URATE-BINDING GLOBULIN, DECREASE IN	0.00408163	0.2040815
AREDYLD	0.00408163	0.2040815
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00408163	0.2040815
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00408163	0.2040815
PROPERDIN DEFICIENCY, X-LINKED	0.00408163	0.2040815
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00408163	0.2040815
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00408163	0.2040815
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00408163	0.2040815
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00408163	0.2040815
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00408163	0.2040815
NEUTROPHIL ACTIN DYSFUNCTION	0.00408163	0.2040815
ALAND ISLAND EYE DISEASE	0.00408163	0.2040815
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00408163	0.2040815
CATECHOL-O-METHYLTRANSFERASE	0.00408163	0.2040815
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00408163	0.2040815
MACULAR DYSTROPHY, CORNEAL, 1	0.00408163	0.2040815
#192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1;;CMH;;VENTRICULAR HYPERTROPHY, HEREDITARY;;ASYMMETRIC SEPTAL HYPERTROPHY; ASH;;HYPERTROPHIC SUBAORTIC STENOSIS, IDIOPATHIC	0.00408163	0.2040815
257960 OCULOTRICHODYSPLASIA; OTD	0.00408163	0.2040815
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.00408163	0.2040815
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00408163	0.2040815
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00408163	0.2040815
DERMATOLEUKODYSTROPHY	0.00408163	0.2040815
OVARIAN CANCER	0.00408163	0.2040815
PREMATURE CENTROMERE DIVISION; PCD	0.00408163	0.2040815
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00408163	0.2040815
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00408163	0.2040815
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00408163	0.2040815
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00408163	0.2040815
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00408163	0.2040815
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00408163	0.2040815
ALKAPTONURIA	0.00408163	0.2040815
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00408163	0.2040815
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00408163	0.2040815
CARBOXYLESTERASE 1	0.00408163	0.2040815
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00408163	0.2040815
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00408163	0.2040815
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00408163	0.2040815
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00408163	0.2040815
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00408163	0.2040815
#270300 PEELING SKIN SYNDROME 1; PSS1;;PSS;;SKIN PEELING, FAMILIAL CONTINUOUS GENERALIZED;;KERATOLYSIS EXFOLIATIVA CONGENITA;;DECIDUOUS SKIN	0.00408163	0.2040815
NEPHROSIALIDOSIS	0.00408163	0.2040815
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00408163	0.2040815
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00408163	0.2040815
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.00408163	0.2040815
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00408163	0.2040815
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00408163	0.2040815
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00408163	0.2040815
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00408163	0.2040815
LUTHERAN SUPPRESSOR, X-LINKED	0.00408163	0.2040815
FINGERPRINT BODY MYOPATHY	0.00408163	0.2040815
CEREBELLOPARENCHYMAL DISORDER V	0.00408163	0.2040815
#217095 CONOTRUNCAL HEART MALFORMATIONS; CTHMTRUNCUS ARTERIOSUS COMMUNIS, INCLUDED;;CONOTRUNCAL ANOMALY FACE SYNDROME, INCLUDED; CAFS, INCLUDED;;DOUBLE-OUTLET RIGHT VENTRICLE, INCLUDED; DORV, INCLUDED;;PERSISTENT TRUNCUS ARTERIOSUS, INCLUDED; PTA, INCLUDED;;INTERRUPTED AORTIC ARCH, INCLUDED	0.00408163	0.2040815
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00408163	0.2040815
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00408163	0.2040815
#203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC;;ATRICHIA, GENERALIZED	0.00408163	0.2040815
CONE-ROD DYSTROPHY 1; CORD1	0.00408163	0.2040815
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00408163	0.2040815
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.00408163	0.2040815
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00408163	0.2040815
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00408163	0.2040815
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00408163	0.2040815
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00408163	0.2040815
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00408163	0.2040815
PREMATURE OVARIAN FAILURE 1	0.00408163	0.2040815
HOOFT DISEASE	0.00408163	0.2040815
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00408163	0.2040815
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00408163	0.2040815
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00408163	0.2040815
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00408163	0.2040815
POLYCYSTIC OVARY SYNDROME 1	0.00408163	0.2040815
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00408163	0.2040815
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00408163	0.2040815
XANTHINURIA, TYPE I	0.00408163	0.2040815
BEETURIA	0.00408163	0.2040815
XM SYSTEM	0.00408163	0.2040815
GONADOBLASTOMA	0.00408163	0.2040815
PITUITARY DWARFISM IV	0.00408163	0.2040815
PROGESTERONE RESISTANCE	0.00408163	0.2040815
SPINAL ARACHNOIDITIS	0.00408163	0.2040815
CHOROIDAL OSTEOMA, BILATERAL	0.00408163	0.2040815
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00408163	0.2040815
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00408163	0.2040815
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00408163	0.2040815
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00408163	0.2040815
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00408163	0.2040815
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00408163	0.2040815
MAGNESIUM, ELEVATED RED CELL	0.00408163	0.2040815
#301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 1;;AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, WITH SNOW-CAPPED TEETH;;AMELOGENESIS IMPERFECTA, X-LINKED 1; AIH1;;ENAMEL HYPOPLASIA, X-LINKED	0.00408163	0.2040815
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00391471	0.1957355
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00391471	0.1957355
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00391471	0.1957355
ADDUCTED THUMBS SYNDROME	0.00391471	0.1957355
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00391471	0.1957355
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00391471	0.1957355
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00391471	0.1957355
CAMPOMELIC DYSPLASIA	0.00391471	0.1957355
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0037177599999999996	0.18588799999999997
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0037177599999999996	0.18588799999999997
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0037177599999999996	0.18588799999999997
MENTAL RETARDATION, X-LINKED 93	0.0037177599999999996	0.18588799999999997
LATERAL MENINGOCELE SYNDROME	0.0037177599999999996	0.18588799999999997
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.0037177599999999996	0.18588799999999997
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.0037177599999999996	0.18588799999999997
SIFRIM-HITZ-WEISS SYNDROME	0.0037177599999999996	0.18588799999999997
JOHANSON-BLIZZARD SYNDROME; JBS	0.0037177599999999996	0.18588799999999997
#119540 CLEFT PALATE, ISOLATED; CPI;;CLEFT PALATE; CPCLEFT PALATE, ISOLATED, AND MENTAL RETARDATION, INCLUDED	0.003716871	0.18584355
MECKEL SYNDROME, TYPE 10; MKS10	0.003716871	0.18584355
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.003716871	0.18584355
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.003716871	0.18584355
#614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;EMARDDMYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET,MILD VARIANT, INCLUDED	0.003716871	0.18584355
2q33.1 deletion syndrome	0.003716871	0.18584355
PARIETAL FORAMINA	0.003716871	0.18584355
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.003716871	0.18584355
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.0036450019999999996	0.18225009999999997
HOLOPROSENCEPHALY 3; HPE3	0.0036450019999999996	0.18225009999999997
CHROMOSOME 15Q14 DELETION SYNDROME	0.0036450019999999996	0.18225009999999997
CDAGS SYNDROME	0.0036450019999999996	0.18225009999999997
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.0036450019999999996	0.18225009999999997
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0036450019999999996	0.18225009999999997
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.0036450019999999996	0.18225009999999997
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0036450019999999996	0.18225009999999997
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0036450019999999996	0.18225009999999997
OROFACIODIGITAL SYNDROME VIII; OFD8	0.0036450019999999996	0.18225009999999997
ROSSELLI-GULIENETTI SYNDROME	0.0036450019999999996	0.18225009999999997
RAINE SYNDROME	0.0036450019999999996	0.18225009999999997
OROFACIODIGITAL SYNDROME IX; OFD9	0.0036450019999999996	0.18225009999999997
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.0036450019999999996	0.18225009999999997
BARATELA-SCOTT SYNDROME	0.0036450019999999996	0.18225009999999997
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0036450019999999996	0.18225009999999997
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.0036450019999999996	0.18225009999999997
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.0036450019999999996	0.18225009999999997
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0036450019999999996	0.18225009999999997
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.0036450019999999996	0.18225009999999997
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.0036450019999999996	0.18225009999999997
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.0036450019999999996	0.18225009999999997
LOWRY-MACLEAN SYNDROME	0.0036450019999999996	0.18225009999999997
Temtamy preaxial brachydactyly syndrome	0.0036450019999999996	0.18225009999999997
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.0036450019999999996	0.18225009999999997
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00358423	0.1792115
#182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A;;SPG3;;STRUMPELL DISEASE;;FAMILIAL SPASTIC PARAPLEGIA, AUTOSOMAL DOMINANT, 1; FSP1	0.00358423	0.1792115
#615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56	0.00358423	0.1792115
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.00358423	0.1792115
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00358423	0.1792115
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00358423	0.1792115
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.00358423	0.1792115
#270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15;;SPASTIC PARAPLEGIA AND RETINAL DEGENERATION;;KJELLIN SYNDROME	0.00358423	0.1792115
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00358423	0.1792115
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00358423	0.1792115
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00358423	0.1792115
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.0035199209999999996	0.17599605
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.0035199209999999996	0.17599605
RETINITIS PIGMENTOSA 59; RP59	0.0035199209999999996	0.17599605
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.0035199209999999996	0.17599605
FILIPPI SYNDROME; FLPIS	0.0035199209999999996	0.17599605
224250 DYSMYELINATION WITH JAUNDICE	0.0035199209999999996	0.17599605
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.0035199209999999996	0.17599605
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.0035199209999999996	0.17599605
ALAZAMI-YUAN SYNDROME	0.003448052	0.17240260000000002
NOONAN SYNDROME 3; NS3	0.003448052	0.17240260000000002
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.003448052	0.17240260000000002
CHROMOSOME 18P DELETION SYNDROME	0.003448052	0.17240260000000002
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.003448052	0.17240260000000002
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.003448052	0.17240260000000002
CHOPS SYNDROME; CHOPS	0.003448052	0.17240260000000002
NOONAN SYNDROME 9; NS9	0.003448052	0.17240260000000002
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.003448052	0.17240260000000002
TOWNES-BROCKS SYNDROME 1; TBS1	0.003448052	0.17240260000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.003448052	0.17240260000000002
MENTAL RETARDATION, X-LINKED 106; MRX106	0.003448052	0.17240260000000002
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.003448052	0.17240260000000002
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.003448052	0.17240260000000002
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.003448052	0.17240260000000002
NOONAN SYNDROME 2; NS2	0.003448052	0.17240260000000002
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.003448052	0.17240260000000002
CREE MENTAL RETARDATION SYNDROME	0.003448052	0.17240260000000002
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.003448052	0.17240260000000002
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.003448052	0.17240260000000002
#614976 CARPENTER SYNDROME 2; CRPT2	0.003448052	0.17240260000000002
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.003448052	0.17240260000000002
GM2-GANGLIOSIDOSIS, AB VARIANT	0.0028732230000000003	0.14366115000000002
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0028732230000000003	0.14366115000000002
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0028732230000000003	0.14366115000000002
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.0028732230000000003	0.14366115000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0028732230000000003	0.14366115000000002
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.0028732230000000003	0.14366115000000002
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0028732230000000003	0.14366115000000002
IMMUNODEFICIENCY 49; IMD49	0.0028732230000000003	0.14366115000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0028732230000000003	0.14366115000000002
KLEEFSTRA SYNDROME 2; KLEFS2	0.0028732230000000003	0.14366115000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0028732230000000003	0.14366115000000002
ANGELMAN SYNDROME	0.0028732230000000003	0.14366115000000002
GRISCELLI SYNDROME, TYPE 1	0.0028732230000000003	0.14366115000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0028732230000000003	0.14366115000000002
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0028732230000000003	0.14366115000000002
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.0028732230000000003	0.14366115000000002
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.0028732230000000003	0.14366115000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.0028732230000000003	0.14366115000000002
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0028732230000000003	0.14366115000000002
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0028732230000000003	0.14366115000000002
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0028732230000000003	0.14366115000000002
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.0028732230000000003	0.14366115000000002
SHUKLA-VERNON SYNDROME; SHUVER	0.0028732230000000003	0.14366115000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0028732230000000003	0.14366115000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0028732230000000003	0.14366115000000002
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0028732230000000003	0.14366115000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0028732230000000003	0.14366115000000002
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0028732230000000003	0.14366115000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0028732230000000003	0.14366115000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0028732230000000003	0.14366115000000002
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0028732230000000003	0.14366115000000002
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0028732230000000003	0.14366115000000002
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0028732230000000003	0.14366115000000002
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.0028732230000000003	0.14366115000000002
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0028732230000000003	0.14366115000000002
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0028732230000000003	0.14366115000000002
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.0028732230000000003	0.14366115000000002
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0028732230000000003	0.14366115000000002
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0028732230000000003	0.14366115000000002
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0028732230000000003	0.14366115000000002
KETOADIPICACIDURIA	0.0028732230000000003	0.14366115000000002
ELEJALDE DISEASE	0.0028732230000000003	0.14366115000000002
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0028732230000000003	0.14366115000000002
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0028732230000000003	0.14366115000000002
JOUBERT SYNDROME 30; JBTS30	0.0028732230000000003	0.14366115000000002
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.0028732230000000003	0.14366115000000002
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0028732230000000003	0.14366115000000002
LUSCAN-LUMISH SYNDROME; LLS	0.0028732230000000003	0.14366115000000002
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.0028732230000000003	0.14366115000000002
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0028732230000000003	0.14366115000000002
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0028732230000000003	0.14366115000000002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.0028732230000000003	0.14366115000000002
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.0028732230000000003	0.14366115000000002
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0028732230000000003	0.14366115000000002
INFANTILE LIVER FAILURE SYNDROME 1	0.0028732230000000003	0.14366115000000002
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.0028732230000000003	0.14366115000000002
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0028732230000000003	0.14366115000000002
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.0028732230000000003	0.14366115000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.0028732230000000003	0.14366115000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0028732230000000003	0.14366115000000002
CHROMOSOME 5Q12 DELETION SYNDROME	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, X-LINKED 90	0.0028732230000000003	0.14366115000000002
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0028732230000000003	0.14366115000000002
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.0028732230000000003	0.14366115000000002
SCHINDLER DISEASE, TYPE I	0.0028732230000000003	0.14366115000000002
SHASHI-PENA SYNDROME; SHAPNS	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0028732230000000003	0.14366115000000002
PELIZAEUS-MERZBACHER DISEASE	0.0028732230000000003	0.14366115000000002
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0028732230000000003	0.14366115000000002
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.0028732230000000003	0.14366115000000002
WIEACKER-WOLFF SYNDROME	0.0028732230000000003	0.14366115000000002
LEIGH SYNDROME; LS	0.0028732230000000003	0.14366115000000002
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0028732230000000003	0.14366115000000002
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0028732230000000003	0.14366115000000002
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.0028732230000000003	0.14366115000000002
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0028732230000000003	0.14366115000000002
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0028732230000000003	0.14366115000000002
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0028732230000000003	0.14366115000000002
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0028732230000000003	0.14366115000000002
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00280112	0.14005599999999999
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00280112	0.14005599999999999
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00280112	0.14005599999999999
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.00280112	0.14005599999999999
MECKEL SYNDROME, TYPE 5	0.00280112	0.14005599999999999
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.00280112	0.14005599999999999
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00280112	0.14005599999999999
HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9	0.00280112	0.14005599999999999
CLEFT PALATE, X-LINKED	0.00280112	0.14005599999999999
SCHNECKENBECKEN DYSPLASIA	0.00280112	0.14005599999999999
CLEFT PALATE-LATERAL SYNECHIA SYNDROME	0.00280112	0.14005599999999999
HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE	0.00280112	0.14005599999999999
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00280112	0.14005599999999999
#608874 OROFACIAL CLEFT 5; OFC5;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 5	0.00280112	0.14005599999999999
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.00280112	0.14005599999999999
TROCHLEA OF THE HUMERUS, APLASIA OF	0.00280112	0.14005599999999999
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00280112	0.14005599999999999
RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE	0.00280112	0.14005599999999999
RAPADILINO SYNDROME	0.00280112	0.14005599999999999
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.00280112	0.14005599999999999
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00280112	0.14005599999999999
KNIEST-LIKE DYSPLASIA, LETHAL	0.00280112	0.14005599999999999
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.00280112	0.14005599999999999
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00280112	0.14005599999999999
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00280112	0.14005599999999999
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00280112	0.14005599999999999
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00280112	0.14005599999999999
#607361 MECKEL SYNDROME, TYPE 3; MKS3;;MECKEL-GRUBER SYNDROME, TYPE 3	0.00280112	0.14005599999999999
HOLZGREVE SYNDROME	0.00280112	0.14005599999999999
CHARGE-LIKE SYNDROME, X-LINKED	0.00280112	0.14005599999999999
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.00280112	0.14005599999999999
AASE-SMITH SYNDROME I	0.00280112	0.14005599999999999
OROFACIODIGITAL SYNDROME X	0.00280112	0.14005599999999999
OCULOPALATOCEREBRAL SYNDROME	0.00280112	0.14005599999999999
OROFACIODIGITAL SYNDROME IV; OFD4	0.00280112	0.14005599999999999
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.00280112	0.14005599999999999
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.00280112	0.14005599999999999
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.00280112	0.14005599999999999
3MC SYNDROME 3	0.00280112	0.14005599999999999
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00280112	0.14005599999999999
OROFACIODIGITAL SYNDROME XI; OFD11	0.00280112	0.14005599999999999
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.00280112	0.14005599999999999
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00280112	0.14005599999999999
VAN DER WOUDE SYNDROME	0.00280112	0.14005599999999999
#200610 ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLYHYPOCHONDROGENESIS, INCLUDED	0.00280112	0.14005599999999999
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME;;ECP SYNDROME	0.00280112	0.14005599999999999
STICKLER SYNDROME, TYPE II	0.00280112	0.14005599999999999
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00280112	0.14005599999999999
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00280112	0.14005599999999999
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00280112	0.14005599999999999
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.00280112	0.14005599999999999
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00280112	0.14005599999999999
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00280112	0.14005599999999999
SAY SYNDROME	0.00280112	0.14005599999999999
PIERRE ROBIN SYNDROME	0.00280112	0.14005599999999999
MICROPHTHALMIA, SYNDROMIC 4	0.00280112	0.14005599999999999
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00280112	0.14005599999999999
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00280112	0.14005599999999999
THORACOABDOMINAL SYNDROME	0.00280112	0.14005599999999999
NEMALINE MYOPATHY 2; NEM2	0.00280112	0.14005599999999999
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.00280112	0.14005599999999999
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00280112	0.14005599999999999
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00280112	0.14005599999999999
CLEIDOCRANIAL DYSPLASIA; CCD	0.00280112	0.14005599999999999
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00280112	0.14005599999999999
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00280112	0.14005599999999999
LOEYS-DIETZ SYNDROME 3; LDS3	0.00280112	0.14005599999999999
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.00280112	0.14005599999999999
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00280112	0.14005599999999999
BASAL CELL NEVUS SYNDROME	0.00280112	0.14005599999999999
TREACHER COLLINS SYNDROME 3; TCS3	0.00280112	0.14005599999999999
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.00280112	0.14005599999999999
DIAMOND-BLACKFAN ANEMIA 10	0.00280112	0.14005599999999999
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.00280112	0.14005599999999999
NAIL-PATELLA SYNDROME	0.00280112	0.14005599999999999
PIERRE ROBIN SYNDROME AND OLIGODACTYLY	0.00280112	0.14005599999999999
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.00280112	0.14005599999999999
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.00280112	0.14005599999999999
STICKLER SYNDROME, TYPE III	0.00280112	0.14005599999999999
PARC SYNDROME	0.00280112	0.14005599999999999
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00280112	0.14005599999999999
%119530 OROFACIAL CLEFT 1; OFC1;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 1;;OROFACIAL CLEFT, NONSYNDROMIC; OFC;;CLEFT LIP/PALATE, NONSYNDROMIC	0.00280112	0.14005599999999999
TREACHER COLLINS SYNDROME 2; TCS2	0.00280112	0.14005599999999999
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.00280112	0.14005599999999999
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.00280112	0.14005599999999999
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B; CPSKF1B	0.00280112	0.14005599999999999
#137215 GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;;GASTRIC CANCER, FAMILIAL DIFFUSEGASTRIC CANCER, FAMILIAL DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFTPALATE, INCLUDED	0.00280112	0.14005599999999999
LYMPHEDEMA, HEREDITARY, II	0.00280112	0.14005599999999999
ACROCRANIOFACIAL DYSOSTOSIS	0.00280112	0.14005599999999999
ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE	0.00280112	0.14005599999999999
OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6	0.00280112	0.14005599999999999
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.00280112	0.14005599999999999
PALATOPHARYNGEAL INCOMPETENCE	0.00280112	0.14005599999999999
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00280112	0.14005599999999999
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00280112	0.14005599999999999
RETINOBLASTOMA; RB1	0.00280112	0.14005599999999999
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.00280112	0.14005599999999999
Ischiocoxopodopatellar syndrome with or without pulmonary arterial hypertension	0.00280112	0.14005599999999999
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.00280112	0.14005599999999999
TEEBI-SHALTOUT SYNDROME; TBSH	0.00280112	0.14005599999999999
#615731 NEMALINE MYOPATHY 9; NEM9	0.00280112	0.14005599999999999
NEU-LAXOVA SYNDROME 2; NLS2	0.00280112	0.14005599999999999
#156550 KNIEST DYSPLASIA	0.00280112	0.14005599999999999
KYPHOMELIC DYSPLASIA	0.00280112	0.14005599999999999
GENITOPALATOCARDIAC SYNDROME	0.00280112	0.14005599999999999
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00280112	0.14005599999999999
Split hand/foot malformation 1 (SHFM1)	0.00280112	0.14005599999999999
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	0.00280112	0.14005599999999999
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00280112	0.14005599999999999
STICKLER SYNDROME, TYPE I	0.00280112	0.14005599999999999
#603543 LIMB-MAMMARY SYNDROME; LMS	0.00280112	0.14005599999999999
MEGAEPIPHYSEAL DWARFISM	0.00280112	0.14005599999999999
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00280112	0.14005599999999999
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00280112	0.14005599999999999
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00280112	0.14005599999999999
#606713 VAN DER WOUDE SYNDROME 2; VWS2	0.00280112	0.14005599999999999
3MC SYNDROME 1	0.00280112	0.14005599999999999
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00280112	0.14005599999999999
MECKEL SYNDROME, TYPE 6; MKS6	0.00280112	0.14005599999999999
#612290 MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATEMICROTIA WITH OR WITHOUT HEARING IMPAIRMENT, INCLUDED	0.00280112	0.14005599999999999
BARTSOCAS-PAPAS SYNDROME; BPS	0.00280112	0.14005599999999999
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00280112	0.14005599999999999
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00280112	0.14005599999999999
MESOMELIC LIMB SHORTENING AND BOWING	0.00280112	0.14005599999999999
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.00280112	0.14005599999999999
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00280112	0.14005599999999999
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.00260417	0.1302085
HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	0.00260417	0.1302085
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00260417	0.1302085
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00260417	0.1302085
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00260417	0.1302085
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00260417	0.1302085
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00260417	0.1302085
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00260417	0.1302085
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.00260417	0.1302085
Rothmund-Thomson syndrome	0.00260417	0.1302085
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00260417	0.1302085
#614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B;;DE BARSY SYNDROME B	0.00260417	0.1302085
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00260417	0.1302085
BLOOM SYNDROME	0.00260417	0.1302085
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00260417	0.1302085
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.00260417	0.1302085
RUVALCABA SYNDROME	0.00260417	0.1302085
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00260417	0.1302085
SECKEL SYNDROME 5; SCKL5	0.00260417	0.1302085
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00260417	0.1302085
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.00260417	0.1302085
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.00260417	0.1302085
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00260417	0.1302085
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.00260417	0.1302085
NOONAN SYNDROME 8; NS8	0.00260417	0.1302085
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.00260417	0.1302085
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00260417	0.1302085
#614858 HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14	0.00260417	0.1302085
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.00260417	0.1302085
HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA	0.00260417	0.1302085
UROFACIAL SYNDROME	0.00260417	0.1302085
#194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATIONSYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME	0.00260417	0.1302085
601095 HARROD SYNDROME	0.00260417	0.1302085
SCARF SYNDROME	0.00260417	0.1302085
HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22	0.00260417	0.1302085
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00260417	0.1302085
MCDONOUGH SYNDROME	0.00260417	0.1302085
#614840 HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11	0.00260417	0.1302085
MICROPHTHALMIA, SYNDROMIC 12	0.00260417	0.1302085
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.00260417	0.1302085
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00260417	0.1302085
#613266 WAARDENBURG SYNDROME, TYPE 4C; WS4C;;WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4C;;WAARDENBURG SYNDROME, TYPE IVC	0.00260417	0.1302085
OMODYSPLASIA	0.00260417	0.1302085
#278250 WRINKLY SKIN SYNDROME; WSS	0.00260417	0.1302085
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.00260417	0.1302085
#615542 TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD	0.00260417	0.1302085
ADRENAL HYPOPLASIA, CONGENITAL	0.00260417	0.1302085
8p23.1 deletion syndrome	0.00260417	0.1302085
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00260417	0.1302085
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00260417	0.1302085
BECKWITH-WIEDEMANN SYNDROME	0.00260417	0.1302085
FLOATING-HARBOR SYNDROME	0.00260417	0.1302085
#614279 46,XY SEX REVERSAL 8; SRXY8;;MALE PSEUDOHERMAPHRODITISM DUE TO DEFICIENCY OF TESTICULAR 17,20-DESMOLASE;TDD	0.00260417	0.1302085
HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16	0.00260417	0.1302085
N SYNDROME	0.00260417	0.1302085
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00260417	0.1302085
BARDET-BIEDL SYNDROME 4; BBS4	0.00260417	0.1302085
OMODYSPLASIA 1; OMOD1	0.00260417	0.1302085
#236700 MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION;HMCS;;KAUFMAN-MCKUSICK SYNDROME	0.00260417	0.1302085
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.00260417	0.1302085
ELLIS-VAN CREVELD SYNDROME	0.00260417	0.1302085
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.00260417	0.1302085
REIFENSTEIN SYNDROME	0.00260417	0.1302085
HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7	0.00260417	0.1302085
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00260417	0.1302085
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.00260417	0.1302085
WIDOW&#39;S PEAK SYNDROME	0.00260417	0.1302085
NOONAN SYNDROME 10; NS10	0.00260417	0.1302085
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00260417	0.1302085
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.00260417	0.1302085
Oliver-McFarlane syndrome	0.00260417	0.1302085
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.00260417	0.1302085
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.002029341	0.10146705
VISCERAL STEATOSIS, CONGENITAL	0.002029341	0.10146705
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.002029341	0.10146705
SPINOCEREBELLAR ATAXIA 47; SCA47	0.002029341	0.10146705
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002029341	0.10146705
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.002029341	0.10146705
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.002029341	0.10146705
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.002029341	0.10146705
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.002029341	0.10146705
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.002029341	0.10146705
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.002029341	0.10146705
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.002029341	0.10146705
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002029341	0.10146705
TAY-SACHS DISEASE; TSD	0.002029341	0.10146705
MENTAL RETARDATION, X-LINKED 1	0.002029341	0.10146705
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002029341	0.10146705
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE	0.002029341	0.10146705
SUDDEN CARDIAC FAILURE, INFANTILE	0.002029341	0.10146705
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.002029341	0.10146705
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.002029341	0.10146705
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.002029341	0.10146705
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002029341	0.10146705
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002029341	0.10146705
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.002029341	0.10146705
COFFIN-LOWRY SYNDROME; CLS	0.002029341	0.10146705
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.001957472	0.0978736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001957472	0.0978736
PEROXISOME BIOGENESIS DISORDER 5B	0.001957472	0.0978736
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.001957472	0.0978736
CHROMOSOME 17P13.1 DELETION SYNDROME	0.001957472	0.0978736
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001957472	0.0978736
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.001957472	0.0978736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.001957472	0.0978736
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.001957472	0.0978736
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.001957472	0.0978736
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.001957472	0.0978736
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001957472	0.0978736
MENTAL RETARDATION, X-LINKED 99	0.001957472	0.0978736
JOUBERT SYNDROME 15	0.001957472	0.0978736
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001957472	0.0978736
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001957472	0.0978736
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.001957472	0.0978736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.001957472	0.0978736
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.001957472	0.0978736
ARIMA SYNDROME	0.001957472	0.0978736
JOUBERT SYNDROME 8	0.001957472	0.0978736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001957472	0.0978736
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001957472	0.0978736
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.001957472	0.0978736
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001957472	0.0978736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.001957472	0.0978736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.001957472	0.0978736
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.001957472	0.0978736
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.001957472	0.0978736
CHROMOSOME 4q21 DELETION SYNDROME	0.001957472	0.0978736
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.001957472	0.0978736
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001957472	0.0978736
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001957472	0.0978736
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.001957472	0.0978736
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.001957472	0.0978736
PEROXISOME BIOGENESIS DISORDER 3B	0.001957472	0.0978736
PEROXISOME BIOGENESIS DISORDER 10B	0.001957472	0.0978736
JOUBERT SYNDROME 27	0.001957472	0.0978736
MARINESCO-SJOGREN SYNDROME; MSS	0.001957472	0.0978736
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.001957472	0.0978736
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001957472	0.0978736
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.001957472	0.0978736
HYPOTONIA-CYSTINURIA SYNDROME	0.001957472	0.0978736
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001957472	0.0978736
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.001957472	0.0978736
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001957472	0.0978736
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.001957472	0.0978736
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.001957472	0.0978736
COHEN-GIBSON SYNDROME; COGIS	0.001957472	0.0978736
AL-RAQAD SYNDROME; ARS	0.001957472	0.0978736
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.001957472	0.0978736
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.001957472	0.0978736
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001957472	0.0978736
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001957472	0.0978736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001957472	0.0978736
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001957472	0.0978736
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.001957472	0.0978736
OROFACIODIGITAL SYNDROME XVI; OFD16	0.001957472	0.0978736
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.001957472	0.0978736
CHROMOSOME 9P DELETION SYNDROME	0.001957472	0.0978736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001957472	0.0978736
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.001957472	0.0978736
SPINOCEREBELLAR ATAXIA 5; SCA5	0.001957472	0.0978736
COFFIN-SIRIS SYNDROME 7; CSS7	0.001957472	0.0978736
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001957472	0.0978736
JOUBERT SYNDROME 28	0.001957472	0.0978736
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.001957472	0.0978736
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.001957472	0.0978736
CHROMOSOME 16Q22 DELETION SYNDROME	0.001957472	0.0978736
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.001957472	0.0978736
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001957472	0.0978736
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.001957472	0.0978736
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.001957472	0.0978736
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.001957472	0.0978736
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.001957472	0.0978736
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.001957472	0.0978736
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.001957472	0.0978736
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001759633	0.08798165
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001759633	0.08798165
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.001759633	0.08798165
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.001759633	0.08798165
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001759633	0.08798165
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001759633	0.08798165
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001759633	0.08798165
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 72	0.001759633	0.08798165
MACDERMOT-WINTER SYNDROME	0.001759633	0.08798165
Cerebral creatine deficiency syndrome 2	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001759633	0.08798165
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001759633	0.08798165
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.001759633	0.08798165
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.001759633	0.08798165
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001759633	0.08798165
CHROMOSOME 16p13.3 DELETION SYNDROME	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001759633	0.08798165
OCULOECTODERMAL SYNDROME; OES	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001759633	0.08798165
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001759633	0.08798165
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001759633	0.08798165
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001759633	0.08798165
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001759633	0.08798165
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001759633	0.08798165
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001759633	0.08798165
Muenke syndrome	0.001759633	0.08798165
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.001759633	0.08798165
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 88	0.001759633	0.08798165
#614483 PORENCEPHALY 2; POREN2	0.001759633	0.08798165
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001759633	0.08798165
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001759633	0.08798165
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.001759633	0.08798165
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.001759633	0.08798165
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001759633	0.08798165
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.001759633	0.08798165
GRACILE BONE DYSPLASIA; GCLEB	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.001759633	0.08798165
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.001759633	0.08798165
WAISMAN SYNDROME; WSMN	0.001759633	0.08798165
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001759633	0.08798165
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001759633	0.08798165
HARTNUP DISORDER	0.001759633	0.08798165
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.001759633	0.08798165
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001759633	0.08798165
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001759633	0.08798165
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001759633	0.08798165
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.001759633	0.08798165
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001759633	0.08798165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001759633	0.08798165
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001759633	0.08798165
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.001759633	0.08798165
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001759633	0.08798165
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.001759633	0.08798165
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001759633	0.08798165
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001759633	0.08798165
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001759633	0.08798165
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001759633	0.08798165
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001759633	0.08798165
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001759633	0.08798165
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.001759633	0.08798165
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.001759633	0.08798165
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.001759633	0.08798165
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.001759633	0.08798165
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001759633	0.08798165
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.001759633	0.08798165
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001759633	0.08798165
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001759633	0.08798165
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.001759633	0.08798165
LANDAU-KLEFFNER SYNDROME	0.001759633	0.08798165
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.001759633	0.08798165
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001759633	0.08798165
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001759633	0.08798165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001759633	0.08798165
COFFIN-SIRIS SYNDROME 10; CSS10	0.00111359	0.0556795
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.00111359	0.0556795
Mulchandani-Bhoj-Conlin syndrome	0.00111359	0.0556795
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00111359	0.0556795
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00111359	0.0556795
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00111359	0.0556795
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.00111359	0.0556795
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.00111359	0.0556795
LEGIUS SYNDROME	0.00111359	0.0556795
NEMALINE MYOPATHY 7; NEM7	0.00111359	0.0556795
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00111359	0.0556795
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00111359	0.0556795
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00111359	0.0556795
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.00111359	0.0556795
SCHOLTE SYNDROME; SHLTS	0.00111359	0.0556795
SOTOS SYNDROME 2	0.00111359	0.0556795
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00111359	0.0556795
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.00111359	0.0556795
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00111359	0.0556795
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00111359	0.0556795
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00111359	0.0556795
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00111359	0.0556795
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00111359	0.0556795
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.00111359	0.0556795
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00111359	0.0556795
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00111359	0.0556795
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.00111359	0.0556795
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00111359	0.0556795
BETHLEM MYOPATHY 2; BTHLM2	0.00111359	0.0556795
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00111359	0.0556795
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00111359	0.0556795
#500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT;;MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT, DUE TO RESPIRATORY CHAINDEFICIENCY;;COX DEFICIENCY MYOPATHY, INFANTILE, TRANSIENT;;RESPIRATORY CHAIN DEFICIENCY, INFANTILE, TRANSIENT	0.00111359	0.0556795
JOUBERT SYNDROME 5	0.00111359	0.0556795
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00111359	0.0556795
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00111359	0.0556795
NEMALINE MYOPATHY 10	0.00111359	0.0556795
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00111359	0.0556795
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00111359	0.0556795
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.00111359	0.0556795
MYOTONIC DYSTROPHY 1	0.00111359	0.0556795
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.00111359	0.0556795
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00111359	0.0556795
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.00111359	0.0556795
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00111359	0.0556795
MYOPATHY, CENTRONUCLEAR, 5	0.00111359	0.0556795
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00111359	0.0556795
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00111359	0.0556795
OSTEOGENESIS IMPERFECTA, TYPE X	0.00111359	0.0556795
PIERSON SYNDROME	0.00111359	0.0556795
SPINOCEREBELLAR ATAXIA 1	0.00111359	0.0556795
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.00111359	0.0556795
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00111359	0.0556795
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00111359	0.0556795
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.00111359	0.0556795
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00111359	0.0556795
GLYCOGEN STORAGE DISEASE IXB	0.00111359	0.0556795
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00111359	0.0556795
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00111359	0.0556795
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00111359	0.0556795
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00111359	0.0556795
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00111359	0.0556795
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.00111359	0.0556795
ACETYL-COA CARBOXYLASE DEFICIENCY	0.00111359	0.0556795
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00111359	0.0556795
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00111359	0.0556795
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00111359	0.0556795
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00111359	0.0556795
SPINOCEREBELLAR ATAXIA 13	0.00111359	0.0556795
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.00111359	0.0556795
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00111359	0.0556795
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00111359	0.0556795
NEMALINE MYOPATHY 4	0.00111359	0.0556795
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00111359	0.0556795
#614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD	0.00111359	0.0556795
DYSTONIA 11, MYOCLONIC	0.00111359	0.0556795
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00111359	0.0556795
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00111359	0.0556795
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00111359	0.0556795
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00111359	0.0556795
DESBUQUOIS DYSPLASIA 1	0.00111359	0.0556795
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.00111359	0.0556795
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00111359	0.0556795
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.00111359	0.0556795
VERVERI-BRADY SYNDROME; VERBRAS	0.00111359	0.0556795
PEROXISOME BIOGENESIS DISORDER 11B	0.00111359	0.0556795
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00111359	0.0556795
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00111359	0.0556795
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.00111359	0.0556795
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00111359	0.0556795
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00111359	0.0556795
SPINOCEREBELLAR ATAXIA 2; SCA2	0.00111359	0.0556795
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00111359	0.0556795
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00111359	0.0556795
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000915751	0.04578755
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.000915751	0.04578755
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000915751	0.04578755
#614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD;;BCKDK DEFICIENCY	0.000915751	0.04578755
#603516 SPINOCEREBELLAR ATAXIA 10; SCA10	0.000915751	0.04578755
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000915751	0.04578755
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000915751	0.04578755
EPILEPSY, READING	0.000915751	0.04578755
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000915751	0.04578755
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000915751	0.04578755
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 100	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000915751	0.04578755
EPILEPSY, BENIGN OCCIPITAL	0.000915751	0.04578755
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.000915751	0.04578755
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000915751	0.04578755
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.000915751	0.04578755
DIAMINOPENTANURIA	0.000915751	0.04578755
HYPER-BETA-ALANINEMIA	0.000915751	0.04578755
HYPERLYSINEMIA, TYPE I	0.000915751	0.04578755
PACHYGYRIA, FRONTOTEMPORAL	0.000915751	0.04578755
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000915751	0.04578755
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000915751	0.04578755
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000915751	0.04578755
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000915751	0.04578755
RAMON SYNDROME	0.000915751	0.04578755
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000915751	0.04578755
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000915751	0.04578755
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000915751	0.04578755
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000915751	0.04578755
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000915751	0.04578755
CEREBELLOPARENCHYMAL DISORDER II	0.000915751	0.04578755
#611755 LEBER CONGENITAL AMAUROSIS 10; LCA10	0.000915751	0.04578755
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000915751	0.04578755
#613707 LEOPARD SYNDROME 3; LPRD3	0.000915751	0.04578755
#200150 CHOREOACANTHOCYTOSIS; CHAC;;LEVINE-CRITCHLEY SYNDROME;;ACANTHOCYTOSIS WITH NEUROLOGIC DISORDER;;NEUROACANTHOCYTOSIS;;CHOREA-ACANTHOCYTOSIS	0.000915751	0.04578755
Angelman syndrome (Type 1)	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, 18	0.000915751	0.04578755
GRISCELLI SYNDROME, TYPE 2; GS2	0.000915751	0.04578755
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000915751	0.04578755
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000915751	0.04578755
HHHH SYNDROME	0.000915751	0.04578755
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000915751	0.04578755
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000915751	0.04578755
#605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3	0.000915751	0.04578755
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.000915751	0.04578755
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000915751	0.04578755
AUTISM	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000915751	0.04578755
#187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;HHT;;OSLER-RENDU-WEBER DISEASE;;ORW DISEASETELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 1, INCLUDED; HHT1, INCLUDED	0.000915751	0.04578755
NEUROFIBROMATOSIS, TYPE II	0.000915751	0.04578755
KIFAFA SEIZURE DISORDER	0.000915751	0.04578755
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.000915751	0.04578755
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000915751	0.04578755
MENTAL RETARDATION, FRA12A TYPE	0.000915751	0.04578755
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000915751	0.04578755
ALZHEIMER DISEASE 3; AD	0.000915751	0.04578755
CRANIOSYNOSTOSIS 2	0.000915751	0.04578755
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.000915751	0.04578755
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000915751	0.04578755
#615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15;;SALIH ATAXIA	0.000915751	0.04578755
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000915751	0.04578755
HUNTINGTON DISEASE; HD	0.000915751	0.04578755
AYME-GRIPP SYNDROME; AYGRP	0.000915751	0.04578755
#309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS;;PARTINGTON SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 1; MRXS1;;MENTAL RETARDATION, X-LINKED, WITH DYSTONIC MOVEMENTS, ATAXIA, ANDSEIZURES;;MENTAL RETARDATION, X-LINKED 36; MRX36	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000915751	0.04578755
PERRAULT SYNDROME 3	0.000915751	0.04578755
#202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1;;FAMILIAL GLUCOCORTICOID DEFICIENCY 1; FGD1;;ADRENAL UNRESPONSIVENESS TO ACTH;;ACTH RESISTANCE	0.000915751	0.04578755
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000915751	0.04578755
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000915751	0.04578755
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	0.000915751	0.04578755
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000915751	0.04578755
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000915751	0.04578755
KEARNS-SAYRE SYNDROME; KSS	0.000915751	0.04578755
FRAGILE X MENTAL RETARDATION SYNDROME	0.000915751	0.04578755
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000915751	0.04578755
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000915751	0.04578755
KUFOR-RAKEB SYNDROME	0.000915751	0.04578755
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000915751	0.04578755
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000915751	0.04578755
INCONTINENTIA PIGMENTI; IP	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000915751	0.04578755
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000915751	0.04578755
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000915751	0.04578755
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000915751	0.04578755
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000915751	0.04578755
HYPOMAGNESEMIA 2, RENAL	0.000915751	0.04578755
#300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT;;HETEROTOPIA, FAMILIAL NODULAR;;PERIVENTRICULAR NODULAR HETEROTOPIA 1; PVNH1;;NODULAR HETEROTOPIA, BILATERAL PERIVENTRICULAR; NHBP; BPNHHETEROTOPIA, PERIVENTRICULAR NODULAR, WITH FRONTOMETAPHYSEAL DYSPLASIA,INCLUDED	0.000915751	0.04578755
#244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1;;KCS;;KENNY-CAFFEY SYNDROME, AUTOSOMAL RECESSIVE	0.000915751	0.04578755
#256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5;;CEROID LIPOFUSCINOSIS, NEURONAL, 5, VARIABLE AGE AT ONSETNEURONAL CEROID LIPOFUSCINOSIS, LATE INFANTILE, FINNISH VARIANT, INCLUDED;;FINNISH vLINCL, INCLUDED	0.000915751	0.04578755
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000915751	0.04578755
THREONINEMIA	0.000915751	0.04578755
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000915751	0.04578755
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 14	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000915751	0.04578755
SJOGREN-LARSSON SYNDROME; SLS	0.000915751	0.04578755
RETT SYNDROME; RTT	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000915751	0.04578755
#610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M;;CDG Im; CDGIm;;DOLICHOL KINASE DEFICIENCY;;DK1 DEFICIENCY	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000915751	0.04578755
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000915751	0.04578755
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000915751	0.04578755
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000915751	0.04578755
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.000915751	0.04578755
CHROMOSOME 15q11-q13 DUPLICATION SYNDROME	0.000915751	0.04578755
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000915751	0.04578755
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.000915751	0.04578755
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000915751	0.04578755
CROUZON SYNDROME	0.000915751	0.04578755
#236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1;;HYDROCEPHALY;;VENTRICULOMEGALY	0.000915751	0.04578755
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000915751	0.04578755
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000915751	0.04578755
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000915751	0.04578755
STURGE-WEBER SYNDROME	0.000915751	0.04578755
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000915751	0.04578755
DYSOSTEOSCLEROSIS	0.000915751	0.04578755
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000915751	0.04578755
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000915751	0.04578755
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000915751	0.04578755
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000915751	0.04578755
GURRIERI SYNDROME	0.000915751	0.04578755
#300558 MENTAL RETARDATION, X-LINKED 30; MRX30;;MENTAL RETARDATION, X-LINKED 47; MRX47	0.000915751	0.04578755
MENTAL RETARDATION, X-LINKED 82	0.000915751	0.04578755
ALEXANDER DISEASE	0.000915751	0.04578755
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000915751	0.04578755
#602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC;;MUSCULAR DYSTROPHY, CONGENITAL, WITH MITOCHONDRIAL STRUCTURAL ABNORMALITIES	0.000915751	0.04578755
HYPERPROLINEMIA, TYPE II	0.000915751	0.04578755
POTOCKI-SHAFFER SYNDROME	0.000915751	0.04578755
ACTH DEFICIENCY, ISOLATED; IAD	0.000915751	0.04578755
HYPOPARATHYROIDISM, X-LINKED	0.000915751	0.04578755
RETINAL DEGENERATION AND EPILEPSY	0.000915751	0.04578755
1p36 microdeletion syndrome	0.000915751	0.04578755
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000915751	0.04578755
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000915751	0.04578755
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000915751	0.04578755
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000915751	0.04578755
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000915751	0.04578755
#240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH	0.000915751	0.04578755
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000915751	0.04578755
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.000915751	0.04578755
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000915751	0.04578755
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000915751	0.04578755
#116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM;;CAVERNOUS ANGIOMA, FAMILIAL;;CAVERNOUS ANGIOMATOUS MALFORMATIONS; CAM;;CEREBRAL CAPILLARY MALFORMATIONSCEREBRAL CAVERNOUS MALFORMATIONS 1, INCLUDED; CCM1, INCLUDED;;CAVERNOUS MALFORMATIONS OF CNS AND RETINA, INCLUDED;;HYPERKERATOTIC CUTANEOUS CAPILLARY-VENOUS MALFORMATIONS ASSOCIATEDWITH CEREBRAL CAPILLARY MALFORMATIONS, INCLUDED	0.000915751	0.04578755
#223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL;;NOREPINEPHRINE DEFICIENCY;;NORADRENALINE DEFICIENCY	0.000915751	0.04578755
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000915751	0.04578755
#615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR ;;PMGR	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000915751	0.04578755
#607136 SPINOCEREBELLAR ATAXIA 17; SCA17;;HUNTINGTON DISEASE-LIKE 4; HDL4	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000915751	0.04578755
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000915751	0.04578755
#300143 MENTAL RETARDATION, X-LINKED 21; MRX21;;MENTAL RETARDATION, X-LINKED 34; MRX34	0.000915751	0.04578755
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000915751	0.04578755
PERRAULT SYNDROME 5; PRLTS5	0.000915751	0.04578755
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000915751	0.04578755
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000915751	0.04578755
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000915751	0.04578755
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000915751	0.04578755
HYPOPHOSPHATASIA, CHILDHOOD	0.000915751	0.04578755
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000915751	0.04578755
#612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3	0.000915751	0.04578755
SUPRABULBAR PARESIS, CONGENITAL	0.000915751	0.04578755
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000915751	0.04578755
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.000915751	0.04578755
Angelman syndrome (Type 2)	0.000915751	0.04578755
FLYNN-AIRD SYNDROME	0.000915751	0.04578755
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000915751	0.04578755
Wolf-Hirschhorn Syndrome	0.000915751	0.04578755
DARIER-WHITE DISEASE; DAR	0.000915751	0.04578755
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000915751	0.04578755
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.0421941
PELLAGRA-LIKE SYNDROME	0.000843882	0.0421941
Leukotriene C4 synthase deficiency	0.000843882	0.0421941
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.0421941
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.0421941
HYPERTRYPTOPHANEMIA; HYPTRP	0.000843882	0.0421941
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.0421941
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.0421941
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.0421941
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.0421941
CURRARINO SYNDROME	0.000843882	0.0421941
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.0421941
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000843882	0.0421941
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.0421941
RICHARDS-RUNDLE SYNDROME; RRNS	0.000843882	0.0421941
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.0421941
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.0421941
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.000843882	0.0421941
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.0421941
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.0421941
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.000843882	0.0421941
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.0421941
NETHERTON SYNDROME; NETH	0.000843882	0.0421941
Cerebral creatine deficiency syndrome 3	0.000843882	0.0421941
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.0421941
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.0421941
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 16; BBS16	0.000843882	0.0421941
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.0421941
Bardet-Biedl syndrome 2	0.000843882	0.0421941
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.0421941
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.0421941
FRONTOOCULAR SYNDROME	0.000843882	0.0421941
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000843882	0.0421941
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.0421941
Jawad syndrome	0.000843882	0.0421941
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.0421941
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.0421941
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000843882	0.0421941
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000843882	0.0421941
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000843882	0.0421941
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000843882	0.0421941
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000843882	0.0421941
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.0421941
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.0421941
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.000843882	0.0421941
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.0421941
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.0421941
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.0421941
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.0421941
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000843882	0.0421941
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.000843882	0.0421941
RAHMAN SYNDROME	0.000843882	0.0421941
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.0421941
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.0421941
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.0421941
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.0421941
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.000843882	0.0421941
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.0421941
BAKER-GORDON SYNDROME; BAGOS	0.000843882	0.0421941
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.0421941
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000843882	0.0421941
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.0421941
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000843882	0.0421941
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.0421941
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.0421941
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000843882	0.0421941
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.0421941
CHAR SYNDROME	0.000843882	0.0421941
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000843882	0.0421941
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000843882	0.0421941
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.0421941
WAARDENBURG-SHAH SYNDROME	0.000843882	0.0421941
SENIOR-LOKEN SYNDROME 9	0.000843882	0.0421941
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.0421941
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.0421941
FRIAS SYNDROME	0.000843882	0.0421941
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000843882	0.0421941
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.0421941
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.0421941
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.0421941
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.0421941
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000843882	0.0421941
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.0421941
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000843882	0.0421941
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.0421941
#614970 JOUBERT SYNDROME 20; JBTS20	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.0421941
#615665 JOUBERT SYNDROME 22; JBTS22	0.000843882	0.0421941
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.0421941
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000843882	0.0421941
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.0421941
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000843882	0.0421941
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.000843882	0.0421941
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000843882	0.0421941
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.0421941
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000843882	0.0421941
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000843882	0.0421941
OROTIC ACIDURIA	0.000843882	0.0421941
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000843882	0.0421941
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.0421941
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000843882	0.0421941
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.0421941
STEEL SYNDROME; STLS	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.0421941
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.000843882	0.0421941
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.0421941
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.0421941
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.0421941
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.0421941
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.0421941
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.0421941
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.0421941
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.000843882	0.0421941
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.0421941
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.0421941
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.0421941
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.0421941
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.0421941
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.0421941
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000843882	0.0421941
#300555 DENT DISEASE 2	0.000843882	0.0421941
SECKEL SYNDROME 8; SCKL8	0.000843882	0.0421941
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000843882	0.0421941
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.0421941
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.000843882	0.0421941
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.0421941
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.0421941
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.0421941
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.0421941
AUSTRALIA ANTIGEN	0.000843882	0.0421941
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.0421941
